| D |
| D Cultrera |
- |
Proposal of Immunotolerance Induction in Haemophiliacs A with Inhibitors Undergoing to Pressing Elective Surgery by Using FVIII/vWF-enriched Pure Plasmaderivates |
| D Borgel D |
- |
Elevated Gas6 Plasma Levels in Patients with Severe Sepsis |
| Dabbous OH |
- |
Bleeding Events with and without Thienopyridines in Patients with Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events |
| |
- |
Bleeding Events with Lytics and Thienopyridines in Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events |
| Dabrio CG |
- |
Effect of Cigarrette Smoking on Fibrinogen and Von Willebrand Factor and Their Association with Risk Factors for Microangiopathy |
| Daddi G |
- |
Postoperative Pulmonary Embolism Detected by Multi-slice Computerized Tomography (MSCT) after Lung Surgery FcOR Cancer |
| Daenens K |
- |
Thrombospondin-1 Secures Thrombus Adherence in vivo by Protecting (Sub)Endothelial VWF from Leavage by ADAMTS13 |
| |
- |
P-selectin Antagonist Gallic Acid is Antithrombotic Via Inhibition of Circulating Tissue Factor Deposition in Developing Murine Arterial Thrombi |
| |
- |
NF279 Inhibits the Contribution of P2X1 to Arteriolar Thrombosis Via Partial Agonism |
| DAF Chamone |
- |
Evaluation of Hemostasis Changes in Patients Underwent Coronary Artery Bypass Graft (CABG). The Partial Results in a Brazilian Hospital |
| Dager W |
- |
Low Dose (<60 mcg/kg) Recombinant Factor VIIa in Trauma or Coagulopathy |
| |
- |
Evaluation of the Warkentin 4 T's Clinical Prediction Tool for Heparin-Induced Thrombocytopenia (HIT): Comparison to the Chong's HIT Classification Score |
| D'Agnano G |
- |
Warfarin Therapy in AF Patients: Females Are Still at Risk |
| Dahan K |
- |
New Mutation Inducing a von Willebrand 2A Disease |
| Dahl OE |
- |
Long-Term Occurrence of Venous Thromboembolism after Major Joint Surgery |
| Dahl OE |
- |
Fatal Vascular Outcomes Following Major Orthopedic Surgery |
| |
- |
Prevention of Venous Thromboembolism with an Oral, Direct Factor Xa Inhibitor BAY 59-7939 in Elective Hip Replacement: A Dose-Ranging Study |
| Dahl O |
- |
ASA and NSAIDs with Melagatran/Ximelagatran or Enoxaparin Do NOT Increase Bleeding in Patients Undergoing Joint Replacement Surgery. The METHRO III Study |
| Dahlbäck B |
- |
Co-segregation of the PROS1 Locus and Protein S Deficiency in Families having no Detectable Mutations in PROS1 |
| |
- |
Large Deletions Explain Protein S Deficiency in Many Cases Where Previous Mutation Detection Has Failed |
| |
- |
In vitro Characterization of Increased Factor V 1 Form by Factor V R2 Haplotype |
| |
- |
Analysis of Gas6 in Human Platelets and Plasma |
| Dahm AEA |
- |
17b-Estradiol Lowers Production of Tissue Factor Pathway Inhibitor (TFPI) in HUVEC Cells |
| Dai J |
- |
Genetic Analysis of Chinese Patients with Inherited Afibrinogenemia |
| Dai J |
- |
Molecular Pathology of Haemophilia B in 19 Unrelated Han's Patients: Identification of Five Novel Mutations |
| Dai KS |
- |
The Association of Arterial Thrombosis and Polymorphisms of Platelet Glycoproteins and von Willebrand Factor in the Chinese Population |
| Dai K |
- |
A Critical Role for 14-3-3 Protein in Regulating the VWF Binding Function of the Platelet Glycoprotein Ib-IX |
| Daikur J |
- |
Comparative Anticoagulant Effects of a Synthetic, Dual Antithrombotic/Antiplatelet Agent, CanAm 208, with Argatroban and Angiomax |
| Dailiana Z |
- |
Factor V Leiden and R2 Mutations, Prothrombin G20210A Mutation and Osteonecrosis |
| Daleskog M |
- |
Food Intake Enhances Platelet Reactivity to Thromboxane in Type 2 Diabetic Patients |
| |
- |
Postprandial Hyperglycaemia Induces Platelet Activation in Type 2 Diabetes Mellitus: Effects of Treatment with Repaglinide and Glibenclamide |
| |
- |
Contrast Medium Attenuates Platelet Activation and Platelet-Leukocyte Cross-Talk |
| |
- |
Inhibition of the Renin-Angiotensin System Does Not Reduce Platelet Activity at Rest or during Stress in Essential Hypertension |
| |
- |
Effects of Improved Metabolic Control on Platelet Reactivity in Patients with Type 2 Diabetes Mellitus Following Coronary Angioplasty |
| |
- |
Effects of Oral Hormone Replacement Therapy (HRT) on Platelet Function, Inflammatory Markers and Matrix Metalloproteinases in Postmenopausal Women with Established Coronary Artery Disease |
| Dallongeville J |
- |
Plasma Levels of Tissue Factor and von Willebrand Factor Predict Long Term Clinical Outcome after Percutaneous Coronary Revascularization |
| Daly ME |
- |
The PAR-1 IVSn-14 A/T Polymorphism Influences TRAP-Induced Platelet Calcium Mobilisation and Platelet Procoagulant Responses |
| Daly ME |
- |
Possible Role for the Von Willebrand Factor Propeptide in Regulating Von Willebrand Factor Expression |
| Dambrink JHE |
- |
Role of Platelet Aggregation Testing in Acute Stent Thrombosis |
| Dämgen-von Brevern G |
- |
Development and Clinical Evaluation of Two Chromogenic Substrate Methods For Monitoring Fondaparinux Sodium |
| DAmico E |
- |
Sticky Platelet Syndrome Is a Cause of Cerebral Venous Thrombosis |
| D'Amico EA |
- |
Thromboembolic Complications of Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: Effects of the Disease and the Therapy on the Hemostatic System |
| D'Amico EA |
- |
Treatment of Extensive Venous Malformation-Associated Localized Intravascular Coagulation with Interferon-Alpha: Case Report |
| D'Amico EA |
- |
Homozygous Protein C Deficiency: A Case Report of Neonatal Purpura Fulminans Treated with Activated Protein C Concentrate and High dose of Enoxaparin |
| Damodar P |
- |
Coagulation Markers as Predictors of Disease Progression in Cancer |
| Damon L |
- |
Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels |
| Danchev D |
- |
Novel Materials Based on Chitosan or Chitosan Derivatives with Improved Blood Compatibility |
| Dandie G |
- |
Venous Thromboembolism and Spinal Surgery |
| DAngelo A |
- |
Association of High Lipoprotein(a) and Fibrinogen Levels Predicts Coronary Heart Disease and Cerebro-vascular Mortality in an Elderly (>=65 years) Northern Italian Population |
| D'Angelo A |
- |
LMWH-Induced Thrombocytopenia (Type II) Successfully Treated with Fondaparinux (Arixtra®) |
| D'Angelo A |
- |
Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions |
| Daniel J-M |
- |
Urokinase Receptor (uPAR)(CD87) Clustering in Detergent Insoluble Adhesion Patches (DIAP) Leads to Cell Adhesion on a Vitronectin Matrix |
| Daniel J-M |
- |
The Factor VII Activating Protease (FSAP) Is an Inhibitor of Neointimal Lesion Formation. Comparison with the Marburg I SNP (G511E) of FSAP |
| Danielsson M |
- |
Prothrombin Time Determination at Ambient Room Temperature |
| |
- |
Prothrombin Time (PT) Determination in Plasma by Wet Chemistry Analysis of Blood with Concomitant Hematocrit Determination, Simple Simon PT |
| Dannenberg H |
- |
CRP Induces Platelet-Endothelial Adhesion Under Flow |
| Darby A |
- |
A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation |
| Dardik R |
- |
Evaluation of Pro-Angiogenic Activity of Factor XIII (FXIII) in Murine Models of Heart Transplantation and FXIII-Deficient Mice |
| Dargaud Y |
- |
Combined Type 1 and Type 2N von Willebrand Disease: Contribution of Real Time PCR in Genotype Study |
| |
- |
Fibrinogen Variants of the Gamma Chain Coiled-Coil Portion Detected by Reverse Phase HPLC in Patients with Venous Thrombosis |
| |
- |
Usefulness of Thromboelastography (ROTEM) for Treatment Management in a Severe Deficiency FXIII Patient with Inhibitor |
| |
- |
Immune Tolerance with FEIBA in a Severe Haemophiliac B with Inhibitor |
| Darnell K |
- |
Identification and Molecular Characterization of a Novel Factor V A2 Domain Tyrosine Deletion Mutation in a Patient with Factor V Deficiency and Bleeding |
| Darstein C |
- |
Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects |
| Dart A |
- |
Shear-dependent Role for Soluble P-selectin in Regulating Neutrophil Adhesion to Platelets |
| Das R |
- |
Prevalence of Risk Factors for Venous Thromboembolism: A Study from North India |
| Das SS |
- |
Influence of Pre Donation Donor Factors on the Yield of Platelets Using Intermittent Flow Cell Separators |
| |
- |
Quality Systems in Automated Plateletpheresis in Hospital Based Blood Transfusion Services in North India |
| Dashevsky O |
- |
Platelet-Derived Microparticles Induce Angiogenesis and Stimulate Post-Ischemic Revascularization |
| |
- |
CRP Induces Platelet-Endothelial Adhesion Under Flow |
| Dashkova N |
- |
Heparin-induced Thrombocytopenia in Patients after Extracorporeal Circulation Surgery |
| Dashti AA |
- |
The Risk of Venous Thrombosis Increases with Co-existence of Multiple Genetic Abnormalities: A Comprehensive Study in Kuwait |
| |
- |
Factor V Kuwait: a New Point Mutation in the Coagulation Factor V Gene |
| Date H |
- |
Detection of von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi Causing Acute Myocardial Infarction |
| Dateki T |
- |
Rational of Pharmacological Effect of a Combination of FVIIa and FX for Hemophilia with Inhibitors |
| DAtri LP |
- |
Regulation of Megakaryocyte Generation by Monocytes/Macrophages |
| D'Atri P |
- |
Role of Human Polymorphonuclear Neutrophils in Endothelial Cell Damage Induced by Shiga Toxin-1 and Inflammatory Agents |
| D'Atri LP |
- |
Cyclic AMP Protects Stem Cell (CD34+) Apoptosis |
| Daurès JP |
- |
The Factor V Leiden and Prothrombin 20210G>A Mutations as Risk Factors for Miscarriage during the First Pregnancy: The Matched CaseControl Big NOHA First Study |
| Daures JP |
- |
Factor V Leiden Mutation and Pregnancy Associated Venous Thromboembolism: A Meta-Analysis |
| Dauzat M |
- |
The Factor V Leiden and Prothrombin 20210G>A Mutations as Risk Factors for Miscarriage during the First Pregnancy: The Matched CaseControl Big NOHA First Study |
| Davagnanam I |
- |
Soluble CD40L in Peripheral Artery Disease: Relationship with Disease Severity, Platelet Markers and the Effects of Angioplasty |
| Davalos A |
- |
Effects of Recombinant Activated Factor VII on Perilesional Oedema in Patients with Acute Intracerebral Haemorrhage |
| Davey M |
- |
The Accuracy of the Wells Pretest Probability Assessment Model for Proximal Deep Vein Thrombosis When Applied by Emergency Department Doctors in South Australia |
| |
- |
Accuracy of a Whole Blood D-Dimer Assay (SimplifyTM) for Deep Vein Thrombosis, When Performed Using Venous Whole Blood and Frozen Plasma in a Cohort Patients with Suspected Deep Vein Thrombosis |
| Davì G |
- |
Determinants of Platelet Activation in Alzheimer's Disease |
| |
- |
Detection of a Critical Degree of Platelet TxA2-Production Inhibition by the PFA100 in Aspirin-Treated Subjects: Possible Relevance for the Monitoring of Aspirin Resistance |
| |
- |
Hypercoagulability May Predict Embryo Implantation after Assisted Reproductive Procedures |
| |
- |
Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria |
| |
- |
Insulin Resistance and Platelet Activation in Obese Women |
| David L |
- |
Neonatal Gene Therapy with Lentiviral Vector in Murine Hemophilia a Results in Successful Immune Tolerance Induction to Canine Factor VIII |
| David D |
- |
The Spectrum of Mutations and Molecular Pathogenesis of Haemophilia A in 163 Portuguese Patients |
| David T |
- |
Mice Lacking the Platelet Glycoprotein Ib Beta Intracellular Domain Display Resistance to Thrombosis But Normal Bleeding Times |
| David-Dufilho M |
- |
The Thrombin-Thrombomodulin Complex Activates Nitric Oxide Synthase 3 through Calmodulin Kinase II and Phosphoinositide 3-kinase Signalling |
| Davido A |
- |
Multi-detector Row Computed Tomography in Outpatients with Suspected Pulmonary Embolism |
| Davidson BL |
- |
Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis |
| Davidson SJ |
- |
Thrombin Potential in Severe Haemophilia A and B Patients |
| Davidson BL |
- |
Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials |
| Davidson SJ |
- |
Following Cardiac Surgery Patients Who Develop Biphasic Waveforms as Seen on the MDA-180 Automated Coagulation Analyser Have Increased Thrombin Potential in-vitro. This Is Partly due to Tissue Factor Present in the CRP-VLDL Complex |
| |
- |
Can the Rotem® Predict Post-Operative Bleeding and Appropriate Treatment after Cardiac Surgery? |
| Davidson BL |
- |
Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis |
| Davidson SJ |
- |
Aspirin Resistance: Platelet Resistance not Non-Compliance |
| Davidson AO |
- |
The b-Fibrinogen -1420G/A Promoter Polymorphism Influences Transcription through Differential Binding of FOXA/HNF3 and May Explain the Association of the -1420A-Containing Haplotype with Elevated Plasma Fibrinogen |
| Davidson BL |
- |
Thromboprophylaxis with Fondaparinux in Acutely Ill Medical Patients Aged 75 years or More, or with Moderate Renal Impairment |
| |
- |
Self-Injection of Fondaparinux (Arixtra®) in the Prophylaxis against Venous Thromboembolism after Major Orthopedic Surgery is Well Accepted, Effective, and Safe: Data from the FLEXTRA Trial |
| Davidson BL |
- |
FLEXTRA: Early vs Delayed Initiation of Postoperative Fondaparinux Prophylaxis after Joint Replacement: A Clinical Outcome Study |
| Davie EW |
- |
Mapping of B Cell Epitopes on the Factor VIII C2 Domain |
| Davie E |
- |
Disruption of an Immunogenic Epitope in the FVIII C2 Domain Results in the Prevention of Anti-FVIII-C2 Inhibitor Formation in BALB/c-FVIIIKO Hemophilic Mice |
| |
- |
Prevention of Anti-FVIII-C2 inhibitor formation Post Protein infusion in Hemophilic Mice By Prior Oral and/or Nasal Exposure of the FVIII-C2 Domain |
| Davies DA |
- |
Endothelial and Platelet Function in Healthy Human Volunteers Treated with Pregabalin: Implications for the Development of Haemangiosarcoma Seen in Mice |
| Davies J |
- |
Introduction of Thromboelastography for Monitoring Haemostatic Function during Pseudomyxoma Peritonei Surgery |
| Davies LW |
- |
Surfaces of Glycoprotein VI Involved in Collagen Binding and Receptor Clustering |
| Davies DA |
- |
Clinical Measurements of Platelet Activation by Flow Cytometry Under Optimised Conditions |
| |
- |
Haemostatic and Haemodynamic Responses to Different Intermittent Pneumatic Compression (IPC) Protocols used for Prophylaxis against Deep Venous Thrombosis (DVT) |
| Davies LW |
- |
Affinity Maturation of Blocking Human Antibodies Against Human Glycoprotein VI |
| Davies SW |
- |
Aspirin Resistance: Platelet Resistance not Non-Compliance |
| Davies LW |
- |
GPVI Deficiency Associated with Unexpected Severe Bleeding in a 33 year Old Patient with Moderate Thrombocytopenia and Autoantibodies Against the Ig-like Domains |
| Davis S |
- |
No Influence of Antiplatelet Therapy on the Outcome of Acute Intracerebral Haemorrhage Treated with Recombinant Activated Factor VII |
| Davis EF |
- |
Effectiveness of Anticoagulant Thromboprophylaxis in Medical Diagnostic/Speciality Subgroups: A Meta-Analysis of Randomised Clinical Trials |
| Davis S |
- |
Effects of Recombinant Activated Factor VII on Perilesional Oedema in Patients with Acute Intracerebral Haemorrhage |
| Dawson DJ |
- |
Management of Injecting Drug Users (IDU) with Deep Vein Thrombosis (DVT): A Delphi Study |
| Dawson D |
- |
Retrospective Calculation of the Modified Wells' Clinical Probability of Pulmonary Embolism: Agreement with Prospective Scoring |
| |
- |
PIOPED Ventilation-perfusion Scan Reporting: The Inter-observer Variation |
| Dawson DJ |
- |
Outreach Anticoagulation Project For Injecting Drug Users With Deep Vein Thrombosis: A Randomised Controlled Trial |
| |
- |
Anaemia in Injecting Drug Users (IDU) with Deep Vein Thrombosis (DVT) |
| Day D |
- |
A Novel Method for Determination of Human Plasma Plasminogen Activator Inhibitor (PAI-1) |
| de Boer HC |
- |
The Interaction of Platelets-tumor Cell Complexes with Vitronectin |
| De Bonis S |
- |
Troponin I and In-Hospital Outcome in Patients with Non-Massive Central Pulmonary |
| de Bruijne ELE |
- |
Genetic Variation in ADP-receptor P2Y12 is Associated with the Stability of Platelet Aggregates in Healthy Subjects |
| De Bruin K |
- |
Production of Anti-ADAMTS-13 Monoclonal Antibodies by DNA Immunization |
| De Candia E |
- |
Platelets Morphological and Functional Characterisation in a Novel Case of Grey Platelet Syndrome: Defective Response to Thrombin, PAR1-AP And PAR4-AP and Correlation with Alpha-Granules Content in the Patient and Four Relatives |
| |
- |
Hydrolysis of Platelet GpV by Alpha-Thrombin: Effects of GpIb and Ligands of Thrombin Exosite I and II |
| De Caterina R |
- |
Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue |
| |
- |
Anti-Inflammatory and Anti-Angiogenic Effects of the Omega-3 Fatty Acid Docosahexaenoate (DHA, 22:6 n-3) Through ERK1/2-Mediated Inhibition of Cyclooxygenase (COX)-2 Expression |
| De Caterina R |
- |
N-3 Polyunsaturated Fatty Acids Selectively Affect Circulating Microparticle Subpopulations in Patients with Myocardial Infarction |
| De Caterina R |
- |
Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue |
| |
- |
Homocysteine (Hcy) Stimulates Endothelial Vascular Cell Adhesion Molecule(VCAM)-1 Via Nuclear Factor(NF)-kB Activation Induced by an Increase of Reactive Oxygen Species (ROS): Protective Role by Natural Antioxidants |
| |
- |
Anti-Angiogenic Action of Peroxisome Proliferator-Activated Receptor(PPAR)g Ligands Through Cox-2-Mediated MMP-9 Expression and Release |
| |
- |
MAP-Kinase/NF-kB-Dependent Endothelial Activation and Inhibition of PI3-kinase/Nitric Oxide Are Both Involved in Pro-Atherogenic Effects of Insulin A Link to the Pathogenesis of Accelerated Atherosclerosis in Diabetes |
| De Caterina R |
- |
Aspirin-Clopidogrel Combination and Trans-Esophageal Echo Parameters Predictive of Thromboembolism in Atrial Fibrillation: The CLAAF-Pilot Study |
| De Cristofaro R |
- |
Ristocetin Accelerates Von Willebrand Factor (VWF) Hydrolysis Rate and Ameliorates Collagen Binding Assay (CBA) Sensitivity |
| De Cristofaro R |
- |
Perturbation of pKa Values of Catalytic Residues in the NATURAL Thrombin: Mutant with Deletion of Lys9 in The A-Chain |
| De Cristofaro R |
- |
Platelets Morphological and Functional Characterisation in a Novel Case of Grey Platelet Syndrome: Defective Response to Thrombin, PAR1-AP And PAR4-AP and Correlation with Alpha-Granules Content in the Patient and Four Relatives |
| |
- |
Hydrolysis of Platelet GpV by Alpha-Thrombin: Effects of GpIb and Ligands of Thrombin Exosite I and II |
| De Cristofaro R |
- |
Role of Chloride Ions in the Modulation of the Interaction between von Willebrand Factor and Adamts-13 |
| de Curtis A |
- |
C-Reactive Protein and Its Determinants in European Populations at Different Risk of Cardiovascular Disease: Results from the IMMIDIET Project |
| De Curtis A |
- |
Polyphenolic Components of Extra Virgin Olive Oil: Effect on Arterial Thrombosis and Bioavailability in Rats |
| De Filippis V |
- |
Hydrolysis of Platelet GpV by Alpha-Thrombin: Effects of GpIb and Ligands of Thrombin Exosite I and II |
| de Gaetano G |
- |
Walking and Modulation of Cardiovascular Risk Factors in Three European Populations: Results from the IMMIDIET Project |
| |
- |
The -675 4G/5G Plasminogen Activator Inhibitor-1 Promoter Polymorphism in House Dust Mite Sensitive Allergic Asthma Patients |
| |
- |
Parnaparin Prevents Platelet-PMN Leukocyte Interaction: New Clues to the Antithrombotic Properties of Low Molecular Weight Heparin |
| |
- |
C-Reactive Protein and Its Determinants in European Populations at Different Risk of Cardiovascular Disease: Results from the IMMIDIET Project |
| |
- |
Leukocyte Activation in Myeloproliferative Disease |
| |
- |
Polyphenolic Components of Extra Virgin Olive Oil: Effect on Arterial Thrombosis and Bioavailability in Rats |
| |
- |
Comparison of Global Risk of Fatal Cardiovascular Disease in Three European Populations Using SCORE Equations: Results from the IMMIDIET Project |
| |
- |
Parnaparin Prevents the Upregulation of Platelet-Leukocyte Interaction in Whole Blood |
| |
- |
Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project |
| |
- |
Polymorphonuclear Leukocytes Express Tissue Factor after Activation with P-Selectin |
| De Giorgi A |
- |
Spontaneously Acquired Factor VIII and IX Inhibitors in a Patient with Sjogren Syndrome |
| de Graaf J |
- |
A Genome-Wide Linkage Scan for Homocysteine Levels Identifies Three Regions of Interest |
| De Graeff PA |
- |
High Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies of Protein S, Protein C or Antithrombin Is Due to Acceleration Rather Than Overall Increased Risk. A Retrospective Family Cohort Study (DESCARTES) |
| |
- |
Absolute Risk of Venous Thromboembolism (VTE) Associated with Oral Contraceptives in Women with Hereditary Deficiencies Of Protein S, Protein C or Antithrombin Strongly Depends on Cosegregation of Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES) |
| de Groot PG |
- |
The Role of Annexin A5 and Anti-Annexin A5 Antibodies in the Antiphospholipid Syndrome |
| de Groot PhG |
- |
Factor XII (fXII) Is Activated by Unfolded Proteins on the Surface of Negatively Charged Substances, Rather than by These Surfaces Themselves |
| De Groot PG |
- |
Interaction of Beta2-Glycoprotein I with Members of the Low-density Lipoprotein Receptor (LDLR) Super Family |
| de Groot PG |
- |
Lupus Anticoagulant Interferes with Detection of Heparin Levels in Plasma |
| |
- |
Pathophysiology of the Antiphospholipid Syndrome |
| de Groot Ph.G. |
- |
Glycation Induces Formation of Cross-b Structure and Activation of Tissue-Type Plasminogen Activator (tPA) and Factor XII |
| de Groot PG |
- |
Active Von Willebrand Factor Is present in Plasma of Patients with Von Willebrand Disease Type 2B Or ADAMTS-13 Deficiency |
| de Groot PhG |
- |
Activation of the Fibrinolytic System by Amyloid Cross-b Structure Results In reply to: Cell Detachment AND Processing of Neuroendocrine Factors |
| de Groot PG |
- |
Insensitivity of Thrombin Potential to Activated Protein C Due to Antibody-Mediated Qualitative or Quantitative Protein S Deficiencies |
| |
- |
Glycoprotein Iba-Mediated Platelet Adhesion and Aggregation to Immobilized Thrombin under Conditions of Flow |
| de Groot PhG |
- |
Binding of Amyloid to the Fibronectin Type I Domain of tPA And Factor XII Induces Activation of the Fibrinolytic System and the Contact System |
| |
- |
C4b-binding Protein and the Risk of Venous Thrombosis |
| de Groot PG |
- |
von Willebrand Factor D'-D3-domains comprise an adhesion site for leukocytes |
| |
- |
Highly Elevated Levels of Von Willebrand Factor in Patients with Liver Cirrhosis Support Platelet Adhesion Despite Its Reduced Functional Capacity |
| |
- |
Platelet Adhesion to Dimeric Beta2-Glycoprotein-I Under Conditions of Flow Is Mediated by Glycoprotein Iba |
| de Groot PhG |
- |
Increased Fibrinolytic Activity in Patients with a More Severe Clinical Phenotype of Severe Hemophilia A |
| De Groot PG |
- |
C-Terminal Domain of Beta2-Glycoprotein I Is Involved in Binding to Apoer2' |
| de Jonge E |
- |
Endotoxemia Induces Factor VIII-mediated Resistance to Activated Protein C in Healthy Humans |
| de Jonge I |
- |
Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect |
| de Kam ML |
- |
Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel on Risk of Venous Thromboembolism Evaluated through Haemostasis Variables and Sex Hormone Binding Globulin |
| |
- |
Comparative Effects of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol, and a Combined Oral Contraceptive Containing Levonorgestrel, on Lipids and Inflammation Markers of Arterial Disease |
| De Kort W |
- |
Platelet ADP Receptor Function Rapidly Deteriorates in Additive Solutions |
| De Kruif MD |
- |
Impaired Thrombus Formation after Sterile Inflammation Induced by Endotoxin in a Murine Carotid Artery Thrombosis Model |
| de Laat HB |
- |
The Role of Annexin A5 and Anti-Annexin A5 Antibodies in the Antiphospholipid Syndrome |
| de Larrañaga G |
- |
Catastrophic Antiphospholipid Syndrome and Kikuchi-Fujimoto Disease: The First Case Reported |
| de Larrañaga G |
- |
Relation Between Plasmatic Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Body and Liver Fat Content |
| de Leeuw PW |
- |
Changes in Fibrinolysis Activity after Angiotensin II Receptor Blockade in Patients Undergoing Renal Artery Angiography |
| de Lorgeril M |
- |
Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project |
| |
- |
Comparison of Global Risk of Fatal Cardiovascular Disease in Three European Populations Using SCORE Equations: Results from the IMMIDIET Project |
| de Maat MPM |
- |
Highly Elevated Levels of Von Willebrand Factor in Patients with Liver Cirrhosis Support Platelet Adhesion Despite Its Reduced Functional Capacity |
| |
- |
Pathogenesis of Increased VWF Levels and the Association with the Risk of Ischemic Stroke: Proteolysis, Inflammation or Genetic Variation? |
| |
- |
Genetic Variation in ADP-receptor P2Y12 is Associated with the Stability of Platelet Aggregates in Healthy Subjects |
| De Maeyer M |
- |
Determination of Interacting Residues within the VWF A3-Domain and the Antithrombotic Antibody 82D6A3 by Docking, Cocrystallisation and Mutagenesis |
| de Maistre E |
- |
Management of Glanzmann's Thrombasthenia Surgery: Contribution of Thrombelastogram (ROTEM®) |
| De Marco L |
- |
Von Willebrand Factor-Mediated Platelet Adhesion in Flowing Blood is Influenced by Hematocrit |
| |
- |
Integrin a2b1 and Glycoprotein VI Dependent Calcium Signals in Platelets Interacting with Acid-Soluble Type I Collagen Under Flow |
| De Mattei M |
- |
Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers |
| De Mattia D |
- |
Hemostatic Alterations in Pediatric Leukemias |
| |
- |
Cerebral Sinovenous Thrombosis during L-Asparaginase Treatment |
| |
- |
Should Asymptomatic Children with Hereditary Haemorrhagic Telangiectasia (HHT) Be Screened for Vascular Malformations? |
| de Mazancourt P |
- |
Fibrinogen Paris IX: A Case of Symptomatic Hypofibrinogenaemia Associated With Bbeta Y236C and Bbeta IVS7 -1G > C Mutations |
| De Mazancourt P |
- |
Fibrinogen Variants of the Gamma Chain Coiled-Coil Portion Detected by Reverse Phase HPLC in Patients with Venous Thrombosis |
| de Mazancourt P |
- |
Intracerabral Hematoma and Congenital Afibrinogenemia |
| de Mestre A |
- |
Injury-Inducible Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and Perturbing Cyclin D1-Cdk4-p21WAF1/Cip1 Assembly |
| De Meyer SF |
- |
False Positives Account For Low Conversion Frequency In Chimeraplasty For Von Willebrand Disease |
| De Michele S |
- |
Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy |
| De Michele R |
- |
Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy |
| De Michele S |
- |
Assessment of Protein S on Hepatopaths at the Last Stage |
| |
- |
Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy |
| de Moerloose P |
- |
A Chromogenic Anti-FIIa Assay for the Assessment of Melagatran Activity in Plasma |
| |
- |
Clinical Management Study of Venous Thromboembolism (VTE) Using the HemosIL D-Dimer |
| |
- |
Aspirin and Clopidogrel Resistance: A Study on 96 Healthy Volunteers and Role of the P2Y12 H1/H2 Gene Polymorphism |
| |
- |
Coagucheck aPTT versus Central Laboratory aPTT for Anticoagulation Management after Cardiopulmonary Bypass |
| |
- |
Combined Deficiency of Factor V and Factor VIII: Compound Heterozygosity For Two Novel Truncating Mutations in ERGIC53/LMAN1 |
| De Moerloose P |
- |
Investigation of Molecular Mechanisms Regulating Fibrinogen Secretion |
| de Moerloose P |
- |
Effect of Statins on Clopidogrel Platelet Inhibition as Measured by ADP Induced Platelet Aggregation and RPFA-P2Y12 (Accumetrics) in Healthy Volunteers |
| |
- |
Heterozygosity for a Novel FGG Trp253Cys Mutation Causes Hypofibrinogenemia by Specifically Impairing Fibrinogen Secretion |
| |
- |
Management Study with the New HemosIL D-Dimer HS For Exclusion of Venous Thromboembolism (VTE) |
| |
- |
Genetic and Phenotypic Analysis of Families with Inherited Hypo- and Dys-fibrinogenemia |
| de Moerloose Ph |
- |
Atherosclerosis in LDLR Knock-Out Mice Immunized with b2GP1: Effect of High Cholesterol Diet and Pravastatin Supplementation |
| de Moerloose P |
- |
Insensitivity of Thrombin Potential to Activated Protein C Due to Antibody-Mediated Qualitative or Quantitative Protein S Deficiencies |
| |
- |
The Activation of Mouse Fibroblasts by Antiphospholipid Antibodies Requires TLR2 |
| de Moerloose Ph |
- |
Clinical Usefulness of D-Dimer Depending on Clinical Probability and Cut-Off Value in Outpatients with Suspected Pulmonary Embolism |
| De Mol B |
- |
Thromboembolic and Bleeding Complications during Non-cardiac Surgery in Patients with Mechanical Heart Valves |
| de Nanteuil G |
- |
Evaluation of PAI-1 Inhibitors in the Microcirculation of the Hamster Cheek Pouch |
| De Negri F |
- |
Spontaneously Acquired Factor VIII and IX Inhibitors in a Patient with Sjogren Syndrome |
| |
- |
Adrenergic and Cholinergic Regulation of Local t-PA Release in Human Vasculature |
| De Palma M |
- |
Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers |
| De Paula EV |
- |
Effects of Warfarin Administration on in vivo Revascularization in a Rat Model of Hindlimb Ischemia |
| De Paula EV |
- |
Molecular Analysis of Two Unrelated Patients with Bernard-Soulier Syndrome Identification of Novel Mutation in Glycoprotein Ib Alpha Gene |
| De Piano LPA |
- |
D-Dimer Assay Used in the Diagnosis of Acute Venous Thromboembolism |
| |
- |
Evaluation of Hemostasis Changes Between Patients Underwent Coronary Artery Bypass Graft (CABG) with and without Cardiopulmonary Bypass. Partial Results of MASS-III Study |
| De Piano LPA |
- |
Oral Anticoagulation Laboratory Control: Comparison between Two Differents Methods |
| de Pont AC |
- |
Endotoxemia Induces Factor VIII-mediated Resistance to Activated Protein C in Healthy Humans |
| De Prost D |
- |
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects |
| De Punzio I |
- |
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial |
| de Roos A |
- |
Right Ventricular Dysfunction and the Pulmonary Obstruction Index Assessed with Helical CT Predict Clinical Outcome During Three-month Follow-up in Patients with Acute Pulmonary Embolism |
| De Rop C |
- |
Dose-dependent Platelet Activation and Microparticle Release by Different Clinical Antithymocyte Globulins |
| De Saint Martin L |
- |
Soluble CD146 in Women with Unexplained Pregnancy Loss: A New Insight. A Paired CaseControl Study |
| de Saint Martin L |
- |
Premature Atherosclerosis in HIV Positive Patients and Cumulated Time of Exposure to Antiretroviral Therapy (SHIVA Study) |
| De Simone C |
- |
Clinical and Pharmacoeconomic Impact of Secondary Prophylaxis in Young-Adults with Severe Hemophilia A |
| |
- |
Assessing Efficacy and Safety of Recombinant Activated Factor VII in Patients with Platelet Functional Abnormalities Undergoing Surgical Procedures |
| |
- |
Recurrent Arterial Thrombosis in Patients Taking Aspirin |
| |
- |
Any Relationship Between Inherited Thrombophilia and Bleeding Phenotype or Vascular Disease in Patients with Hemophilia and von Willebrand Disease? |
| De Stefano V |
- |
Risk of Recurrent Venous Thromboembolism Associated with Inherited Deficiency of Natural Anticoagulants |
| De Tinteniac A |
- |
Supperiority of Intermittent Pneumatic Compression of the legs over Elastic Stockings to Prevent Venous Thrombosis in Patients with Acute Intra-Cerebral Hemorrhage: A Randomized Trial |
| De Visser MCH |
- |
Haplotypes of the Fibrinogen Genes, Plasma Fibrinogen Levels and the Risk of Deep Venous Thrombosis |
| de Visser MCH |
- |
Interleukin 1 Haplotypes and the Risk of Venous Thrombosis |
| |
- |
The Effect of ABO Blood Group Genotypes on the Loading of von Willebrand Factor with A and B Antigens |
| |
- |
The Marburg I Polymorphism of Factor Seven-Activating Protease Is Not Associated with Venous Thrombosis |
| |
- |
ABO Blood Group Genotypes and the Risk of Venous Thrombosis: Effect of Factor V Leiden |
| De Vos R |
- |
Thrombospondin-1 Secures Thrombus Adherence in vivo by Protecting (Sub)Endothelial VWF from Leavage by ADAMTS13 |
| |
- |
The b1-Tubulin Q43p Functional Polymorphism Reduces the Risk of Cardiovascular Disease by Modulating Platelet Function and Structure |
| de Vries M |
- |
The Importance of the Low-Density Lipoprotein Receptor-Related Protein (LRP) and Megalin Receptor in the Clearance of Factor VIII in Humans |
| De Vriese AS |
- |
Evidence for a Critical Role of the Modifying Subunit of Glutamatecysteine Ligase in Homocysteine Pathophysiology |
| de Winter RJ |
- |
P-selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction |
| de Wolf JThM |
- |
Red Bloodcell Concentrates Reduces Clot Strength Measured with the Thrombelastograph® (TEG) |
| |
- |
The Effect of Platelet Count on the Thrombelastograph® (TEG) Parameters |
| Deane C |
- |
Ambulatory Therapy of Patients with Free-Floating Proximal Deep Vein Thrombosis Is Safe |
| Dear AE |
- |
Amiloride Inhibits Urokinase Type Plasminogen Activator-Mediated Proteolytic Activity and Increases Plasminogen Activator Inhibitor Type-1 mRNA Expression in Aortic Vascular Smooth Muscle Cells |
| DeBernardo S |
- |
WAY-197697, a P-selectin Antagonist, Reduces Atherosclerosis in Apolipoprotein E Deficient Mice |
| |
- |
A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation |
| Debili N |
- |
A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca2+ Signaling in Megakaryocytopoiesis |
| Debili N |
- |
Apaf-1 and Caspase 9 Regulate Early and Late Stages of Megakaryocyte Differentiation |
| Debray M |
- |
Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product |
| Decker K |
- |
Telephone Consultation Provided by the Hemophilia Treatment Centre A Significant Part of the Service |
| |
- |
A System to Track Coagulation Factor Concentrates Can Decrease Waste |
| |
- |
Comparing Bleed Frequency and Factor Concentrate Use Between Haemophilia A and Haemophilia B |
| Deckers NM |
- |
Annexin A5 Regulates the Engulfment Protein Repertoire on the Membrane of PS Expressing Apoptotic Cells |
| Decking UM |
- |
Endogenous Myocardial FVIII:C, von Willebrand Factor (vWF) and Fibrinogen Are Independent of Regional Myocardial Blood Flow (RMBF) |
| Deckmyn H |
- |
Determination of Interacting Residues within the VWF A3-Domain and the Antithrombotic Antibody 82D6A3 by Docking, Cocrystallisation and Mutagenesis |
| |
- |
Different Active Conformations Are Induced in the Collagen Receptor Integrin a2b1 by Outside Manipulation and Inside-out Signalling |
| |
- |
Non-helical Peptide Sequence SRHPRVGVYHVFDSA Binds Specifically to Human Integrin a2b1 |
| |
- |
Functional Evidence for Three I-domain Activation States for Platelet a2b1 Integrin |
| |
- |
A Gain of Function Mutation in aIIbb3 Results in a Glanzmann Thrombasthenia Phenotype |
| |
- |
Crosstalk Between Integrins a2b1 and aIIbb3 during Platelet Activation |
| |
- |
Shielding of the A1-Domain by the Amino-Terminal Domain (AA7641035) of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V |
| |
- |
Humanisation of an Antithrombotic Anti-von Willebrand Factor (VWF) Monoclonal Antibody, 82D6A3, by Variable Domain Resurfacing |
| |
- |
Production of Anti-ADAMTS-13 Monoclonal Antibodies by DNA Immunization |
| |
- |
Intracellular PAR Antagonists Have Anticoagulant and Antithrombotic Properties |
| |
- |
False Positives Account For Low Conversion Frequency In Chimeraplasty For Von Willebrand Disease |
| |
- |
Combination of Loss of Function of Recombinant R1334A-VWF and Gain of Function of R1336A-VWF Results in a Loss of Function of RKR1334-1335-1336A-VWF |
| |
- |
Development of a High-throughput ELISA Assay to Study Platelet Function |
| |
- |
Time Dependent Increase in Thrombus Size Formed under Flow Conditions upon Exposure to Collagen Correlates Inversely with Surface Expressed VWF |
| |
- |
Evidence That the Holes in Immobilized Fibrinogen Are Always Available |
| |
- |
Cloning Strategy and Humanization of the Potent Antithrombotic Agent 6B4, an Anti-Glycoprotein Ib Monoclonal Antibody |
| Declerck PJ |
- |
Elucidation of the Binding Regions of TAFI Neutralising Antibodies Reveals Different Molecular Targets for Thrombin vs Plasmin Mediated TAFI Activation |
| Declerck PJ |
- |
Expression and Characterization of Rat TAFI |
| |
- |
A Rational Approach For Stabilization Of Activated TAFI (TAFIa) |
| |
- |
Characterization of ELISA's Exclusively Reacting with TAFI, the Released Activation Peptide from TAFI and Activated TAFI Using an in vitro Clot Lysis Assay |
| |
- |
Construction and Characterization of MA-T94H3 Derivatives, a TAFI Neutralizing Antibody |
| Decousus H |
- |
Anti-fibrinolytic Use in Major Orthopaedic Surgery Reduces Allogeneic Blood Transfusion. A Meta-analysis of Randomised Trials |
| |
- |
Confirmation of the Pathogenic Role of Ig M and Ig A Anti Heparin-PF4 Antibodies in Patients with Heparin-Induced-Thrombocytopenia |
| |
- |
Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials |
| |
- |
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: Do Perceived Risk Factors for Bleeding Influence Physicians' Practices? Findings From the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) |
| |
- |
Clinical Experience with Retrievable ALN Vena Cava Filters |
| |
- |
The Influence of Previous or Currently Active Cancer on Venous Thromboembolism Prophylaxis Prescribing Practices in Acutely Ill Medical Patients |
| |
- |
Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials |
| |
- |
Predictive Factors for Fatal Pulmonary Embolism in 9902 Patients Presenting with an Episode of Venous Thromboembolism. Findings from the RIETE Registry |
| Defoor J |
- |
The b1-Tubulin Q43p Functional Polymorphism Reduces the Risk of Cardiovascular Disease by Modulating Platelet Function and Structure |
| Degen JL |
- |
Cardiac Involvement in Pathologic Findings of Factor XIII Knockout Mice |
| Degerstrom J |
- |
The Effect of Two Strenuous Physical Exercise Bouts on the Activation of Blood Cells |
| DeGrado WF |
- |
Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function |
| Deguchi H |
- |
Venous Thrombosis in Males Is Associated with Dyslipoproteinemia Involving High Density Lipoprotein (HDL) Deficiency and Excess Low Density Lipoprotein (LDL) |
| |
- |
Adiponectin Correlation with Plasma Lipoprotein Subclasses Determined by NMR and with the Risk of Venous Thrombosis |
| |
- |
Genotype Associations with Dyslipoproteinemia in Male Venous Thrombosis Patients |
| Dehmel H |
- |
Therapeutic Monitoring Using Rotation Thromboelastometry in Patients with Coagulation Factor VIII Inhibitors |
| |
- |
Rotation Thromboelastometry in Patients Receiving Platelet Transfusion after Chemotherapy |
| Dejaeghere D |
- |
Cloning Strategy and Humanization of the Potent Antithrombotic Agent 6B4, an Anti-Glycoprotein Ib Monoclonal Antibody |
| del Aguila MA |
- |
The Relationship Between INR Time-In-Range and Risk of Stroke and Major Bleeds in Chronic Non-Valvular Atrial Fibrillation Warfarin Utilizers |
| del Conde I |
- |
Receptors, Rafts, and Microvesicles in Thrombosis and Inflammation |
| Del Re L |
- |
Determinants of Platelet Activation in Alzheimer's Disease |
| del Rey ML |
- |
Synergism between Functional Hemostatic Polymorphisms and Risk of Premature Myocardial Infarction |
| |
- |
Pharmacogenetic Effect of Factor VII -323 Del/Ins Polymorphism on Diurnal Variation of Factor VII Coagulant Activity and INR in Steady Anticoagulated Patients with Atrial Fibrillation |
| |
- |
Protective Role of the Platelet GP IIIa Polymorphism HPA-1 (PlA) in Subarachnoid Hemorrhage |
| Del Rosso M |
- |
Systemic Sclerosis: Gene Expression Profiling by Microarray Technology of Endothelial Cells |
| Del Turco S |
- |
N-3 Polyunsaturated Fatty Acids Selectively Affect Circulating Microparticle Subpopulations in Patients with Myocardial Infarction |
| Del Vecchio GC |
- |
Hemostatic Alterations in Pediatric Leukemias |
| DeLa Cadena RA |
- |
A Synthetic Peptide Derived From Thrombospondin-1 (TSP1) Type 3 Repeats Modulates Angiogenesis and the Disease Course in an Animal Model of Rheumatoid Arthritis (RA) by Down-Regulating Connective Tissue Growth Factor (CTGF) Expression |
| DeLa Cadena R |
- |
Extremely High Levels of Thrombospondin-1 in a Patient Afflicted with Rheumatoid Arthritis are Correlated with Activation of the Coagulation and Fibrinolytic Systems |
| Dela Cruz RG |
- |
Disruption of a Hydrophobic Cluster Surrounding Tyearosine-131 in the Native Conformation of Antithrombin III Activates it for Factor Xa Inhibition and Increases Its Affinity for Heparin |
| Delahousse B |
- |
Fibrinogen-Aa Thr 312 Ala and Factor XIII Val 34 Leu Polymorphisms in Idiopathic Venous Thromboembolism |
| Delain4 M |
- |
Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study |
| Delecroix E |
- |
Usefulness of Thromboelastography (ROTEM) for Treatment Management in a Severe Deficiency FXIII Patient with Inhibitor |
| |
- |
Usefulness of Thromboelastography (ROTEM®) in Coagulation Management in Trauma Patient |
| Delesque N |
- |
Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells |
| Delesque N |
- |
VEGF-R2 and Neuropilin-1 Are Involved in VEGF-A-Induced Differenciation of Human Bone Marrow Progenitor Cells |
| Delgado AV |
- |
Effects of Hypothermia and Acidosis on Swine Platelet Activation and Aggregation in vivo |
| Delgado AV |
- |
Effects of Acidosis and Hypothermia on Whole Blood Clotting Function in Swine |
| |
- |
Differential Effects of Acidosis and Hypothermia on Clot Development in Swine |
| Delisle L |
- |
The Whole Blood Platelets Aggregation Test for HIT Diagnosis |
| Deliu A |
- |
Elucidation of the Binding Regions of TAFI Neutralising Antibodies Reveals Different Molecular Targets for Thrombin vs Plasmin Mediated TAFI Activation |
| |
- |
Expression and Characterization of Rat TAFI |
| Della Valle P |
- |
LMWH-Induced Thrombocytopenia (Type II) Successfully Treated with Fondaparinux (Arixtra®) |
| Dellgren G |
- |
Therapeutic Endogenous Ligand/Receptor Induction of the VEGF-Angiopoietin System after Intramyocardial Gene Transfer during Myocardial Ischemia |
| DeLucca I |
- |
Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis |
| Delves G |
- |
Seminal Factor VIII and von Willebrand Factor: A Possible Role of the Conventional Clotting System in Human Semen? |
| |
- |
Quantitation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Human Semen |
| Dementieva I |
- |
Oxidized Fibrinogen Affects Blood Rheology (in vitro Study) |
| |
- |
Heparin-induced Thrombocytopenia in Patients after Extracorporeal Circulation Surgery |
| |
- |
Diagnostic Importance of C-Reactive Protein and D-Dimer in Critically Ill Patients |
| Demers C |
- |
Efficacy of the PFA-100® as a Screening Tool for Platelet Dysfunction |
| Demeulemeester D |
- |
Modulation of Angiogenesis during Adipose Tissue Development in Murine Models of Obesity |
| Demina E |
- |
The Study of Genetics Risk Factors Predisposing to Myocardial Infarction in Young Men |
| Demir M |
- |
The Relationship between Pro-Inflammatory Cytokine Levels and Fibrinolytic System in Simple Obese Patients |
| |
- |
The Prevalence of Von Willebrand's Disease in Trakya Region of Turkey |
| Demir M |
- |
Upregulation of Inflammatory Mediators in ESRD Patients: Pathophysiologic Implications |
| Demir M |
- |
The Correlation among Tissue Factor Pathway, Endothelial Damage Parameters and Lipid Profile in Children with Type 1 Diabetes Mellitus |
| Demir |
- |
Hyperhomocysteinemia in Cancer Patients with Thrombosis Is Not Associated with Methylene Tetrahydrofolate Reductase (MTHFR) Gene Mutations and Can Be Down Regulated by Low Molecular Weight Heparin Treatment |
| Demiral HM |
- |
Transfusion of Blood Products in Trauma Patients with Lethal Hemorrhagic Shock |
| Demirel GY |
- |
The Role of Gamma-Glutamyltransferase Activity on Early Platelet Apoptotic Process |
| |
- |
The Effects of Clopidogrel and Nadroparine on Elevated Thrombolytic Risk and Apoptotic Process in Hypercholesterolemia |
| Dempfle CE |
- |
Mortality Prediction Using Coagulation Parameters in Patients with Sepsis: The New Overt DIC Scoring System in Comparison with APACHE II and LOD Score |
| |
- |
CRP as a Biochemical Wells Score? A Double Approach (D-Dimer Plus CRP) in the Diagnosis of Deep Vein Thrombosis Data from the CARDIM Study |
| Dempfle CE |
- |
Predictive Value of ISTH DIC-Score and aPTT Waveform Analysis at Admission to the ICU |
| |
- |
Sensitivity and Specificity of a Rapid Quantitative Point of Care D-Dimer Assay (Cardiac D-dimer) in the Diagnosis of Deep Vein Thrombosis |
| Dempfle CE |
- |
Implication of Local Versus Independent Assessment of Reference Test for Accuracy of a Rapid Point-of Care Quantitative Assay for D-dimer (Cardiac D-dimer) in the Diagnosis of Deep Vein Thrombosis |
| Dempfle CE |
- |
Platelet Contractile Force and Clot Elastic Modulus Measured by Hemodyne Apparatus in Intensive Care Unit Patients: Identification of Patients with High Bleeding Risk |
| Demyanets S |
- |
Hepatocyte Growth Factor Mediates Induction of PAI-1, Il-6 And Il-8 in Human Adipose Tissue |
| |
- |
Cardiac Myocytes and Cardiac Fibroblasts Are Actively Involved in the Recruitment of Monocytes |
| den Heijer M |
- |
Low Methionine Concentration as a Risk Factor for Recurrent Venous Thrombosis |
| |
- |
A Genome-Wide Linkage Scan for Homocysteine Levels Identifies Three Regions of Interest |
| |
- |
Evidence for a Critical Role of the Modifying Subunit of Glutamatecysteine Ligase in Homocysteine Pathophysiology |
| |
- |
Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A Randomised, Placebo-Controlled, Double Blind Trial |
| den Heijer M |
- |
Low Plasma Levels of Vitamin B6 and Recurrent Venous Thrombosis: Risk Assessment and Effect of Combined Vitamin Supplementation in the VITRO-Trial |
| Denecke B |
- |
Enhanced Blood Coagulation and Fibrinolysis in Mice Lacking Histidine-Rich Glycoprotein/HRG |
| Deneys V |
- |
Angiographic Documentation of the Efficacy of Recombinant Activated Factor VII (Novo Seven) to Control Diffuse Bleeding in Major Trauma |
| |
- |
Exposure to Diesel Nanoparticles Does Not Induce Blood Hypercoagulability in an at-Risk Population |
| Denis CV |
- |
Genetic Defects of von Willebrand Factor as a Determinant of Its Survival in the Circulation |
| Denis CV |
- |
C4b-binding Protein (C4BP) Prolongs the Survival of Human Protein S in an Experimental Mouse Model |
| |
- |
von Willebrand Factor D'-D3-domains comprise an adhesion site for leukocytes |
| Denisa W |
- |
Aspirin Induces Receptor Shedding in Platelets by TNFaConverting Enzyme (TACE) |
| Denninger H |
- |
Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency |
| Dennison D |
- |
Clinical Profile of Glanzmann's Thrombasthenia from the Sultanate of Oman |
| DeNofrio JC |
- |
Genetic Manipulation of Megakaryocytes to Study Platelet Integrin Regulation |
| Dent J |
- |
Interaction of Selected Septin Proteins with Platelet Microtubules: Role in the Regulation of Platelet Exocytosis |
| Dentali F |
- |
Abdominal Obesity and the Risk of Recurrent Deep Vein Thrombosis |
| |
- |
Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study |
| |
- |
Prevalence of the Metabolic Syndrome in Patients with Provoked or Unprovoked Deep Vein Thrombosis and in Controls |
| Depasse F |
- |
The Oral, Direct Factor Xa Inhibitor BAY 59-7939 Inhibits Thrombin Generation in vitro after Tissue Factor Pathway Activation |
| |
- |
Effect Of BAY 59-7939 A Novel, Oral, Direct Factor Xa Inhibitor on Clot-Bound Factor Xa Activity in vitro |
| Depka M |
- |
Dose-dependent Platelet Activation and Microparticle Release by Different Clinical Antithymocyte Globulins |
| Depraetere H |
- |
Non-helical Peptide Sequence SRHPRVGVYHVFDSA Binds Specifically to Human Integrin a2b1 |
| Depunzio I |
- |
Coagulation Screening for Otorhinolaryngoiatric Surgery: A Pharmacoeconomic Appraisal in the Setting of the Italian National Health System |
| Derenne S |
- |
Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register |
| Derksen RHWM |
- |
The Role of Annexin A5 and Anti-Annexin A5 Antibodies in the Antiphospholipid Syndrome |
| |
- |
Lupus Anticoagulant Interferes with Detection of Heparin Levels in Plasma |
| |
- |
Interaction of Beta2-Glycoprotein I with Members of the Low-density Lipoprotein Receptor (LDLR) Super Family |
| |
- |
Pathophysiology of the Antiphospholipid Syndrome |
| |
- |
Platelet Adhesion to Dimeric Beta2-Glycoprotein-I Under Conditions of Flow Is Mediated by Glycoprotein Iba |
| |
- |
C-Terminal Domain of Beta2-Glycoprotein I Is Involved in Binding to Apoer2' |
| DeRosa L |
- |
Tissue Factor Pathway Inhibitor (TFPI) during Heparin Therapy in the Paediatric Intensive Care Unit (PICU) |
| |
- |
Developmental Haemostasis and Response to Heparin Therapy in Children |
| Desai H |
- |
CD40 and CD40 Ligand (CD40L) in Primary Hemostasis and Antibody-Mediated Platelet Activation |
| Desai S |
- |
Prospective Study of the Diagnosis of Pulmonary Embolism (PE) Using Pretest Probability (PTP), D-Dimer (DD) and Appropriate Imaging |
| Desai H |
- |
Importance of Pre-Analytical Variables in the Measurement of Platelet-Derived Microparticles |
| |
- |
Cellular Effects of Heparin-PF4 Antibodies and Its Relevance to the Pathogenesis of Heparin-Induced Thrombocytopenia |
| Descourt R |
- |
Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Recurrent Venous Thrombo-Embolism in Cancer Patients: Data from a Hospital-Based Case-Control Study |
| |
- |
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Drug Use and the Risk of Venous Thromboembolism: Results of an Ongoing Hospitalized-Based CaseControl Study |
| |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients |
| Deshayes A |
- |
Activated Protein C Resistance and Factor V Arg306Thr Mutation: A Case Report |
| Desjardins L |
- |
The VEINES-QOL/Sym Questionnaire Is a Valid and Reliable Measure of Quality of Life in Patients with Deep Venous Thrombosis |
| Desmarais S |
- |
The VEINES-QOL/Sym Questionnaire Is a Valid and Reliable Measure of Quality of Life in Patients with Deep Venous Thrombosis |
| Desmond JF |
- |
Structure-Function Analysis of the Prostaglandin H2 Synthase-1 Peroxidase Site |
| Desmyter L |
- |
Exposure to Diesel Nanoparticles Does Not Induce Blood Hypercoagulability in an at-Risk Population |
| Desvard F |
- |
The TM -1208/-1209delTT Gene Promoter Polymorphism and Circulating Monocyte Thrombomodulin (TM) Gene Expression in 100 Healthy Volunteers |
| Deutsch V |
- |
Enrichment of Early Megakaryocyte Progenitors and Their Ex-Vivo Expansion for Transplantation |
| Deutsch V |
- |
A New Approach for Pre Analytical Screening of Hospitalized Patients Receiving Anticoagulant Therapy |
| |
- |
Comparative Analysis of Methods for Assessment of Circulating Endothelial Progenitor Cells Indicated Heterogeneity of Subpopulations at Various Stages of Differentiation |
| deVeber GA |
- |
Recurrent Stroke: The Role of Prothrombotic Disorders |
| Develter J |
- |
Construction and Characterization of MA-T94H3 Derivatives, a TAFI Neutralizing Antibody |
| Devenish R |
- |
Diagnosing and Treating Haemorrhagic Disorders in a Developing Country |
| Deville A |
- |
Molecular Basis of MYH9-Related Disorders in a Series of Ten Families |
| Dewaele J |
- |
Antigen Binding Site Glycosylation Determines the Anticoagulant Activity of a Type II Factor VIII Antibody without Modifying Affinity or Epitope Specificity |
| Dewald G |
- |
Hereditary Angioedema with Normal C1 Esterase Inhibitor: Studies on Two Families with Affected Women and Men |
| Dewald G |
- |
Treatment with Pasteurized C1 Inhibitor Concentrate in Abdominal Pain Attacks of Patients with Hereditary Angioedema |
| Dewar L |
- |
Simultaneous and Coordinate Activation of Human Platelet PAR-1 and PAR-4 by Sub-Nanomolar Thrombin |
| |
- |
Platelets Provide Factor IX (FIX) and Factor X (FX) to Support Dilute Tissue-factor Dependent Coagulation |
| |
- |
Four Direct Thrombin Inhibitors (DTIs) Variably Increase the Prothrombin Time: A Consequence of Differing Therapeutic Molar Concentrations? |
| Dewerchin M |
- |
Antigen Binding Site Glycosylation Determines the Anticoagulant Activity of a Type II Factor VIII Antibody without Modifying Affinity or Epitope Specificity |
| Dexter M |
- |
Venous Thromboembolism and Spinal Surgery |
| Dhanasekharan D |
- |
Transcriptional Regulatory Elements in the 5'-Upstream Region of Gaq Gene in a Human Megakaryocytic Cell Line |
| Dhanjal TS |
- |
Regulation of Spreading in PECAM-1 Knock-Out Mouse Platelets |
| Dhundale A |
- |
Platelets Express Steroidogenic 17bhydroxysteroid Dehydrogenases: Distinct Profiles Predict the Essential Thrombocythemic Phenotype |
| Di MG |
- |
Cardiovascular Risk Factors and the Risk of Venous Thromboembolism |
| Di Castelnuovo A |
- |
Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project |
| Di Castelnuovo A |
- |
The -675 4G/5G Plasminogen Activator Inhibitor-1 Promoter Polymorphism in House Dust Mite Sensitive Allergic Asthma Patients |
| |
- |
Walking and Modulation of Cardiovascular Risk Factors in Three European Populations: Results from the IMMIDIET Project |
| |
- |
C-Reactive Protein and Its Determinants in European Populations at Different Risk of Cardiovascular Disease: Results from the IMMIDIET Project |
| Di Cera E |
- |
Prolonged Anticoagulation and Sustained Therapeutic Endogenous Activated Protein C (APC) Levels during Protein C Activation in Primates by a Thrombin Variant |
| Di Cuonzo F |
- |
Cerebral Sinovenous Thrombosis during L-Asparaginase Treatment |
| Di Febbo C |
- |
Determinants of Platelet Activation in Alzheimer's Disease |
| Di Giusto DA |
- |
Multivalent Circular Aptamers: Therapeutic Candidates for Vascular Indications |
| di Iasio, mg1 |
- |
Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions |
| Di Iorio A |
- |
Determinants of Platelet Activation in Alzheimer's Disease |
| Di Maio C |
- |
Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy |
| |
- |
Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy |
| |
- |
Assessment of Protein S on Hepatopaths at the Last Stage |
| Di Minno G |
- |
Clinical and Pharmacoeconomic Impact of Secondary Prophylaxis in Young-Adults with Severe Hemophilia A |
| |
- |
Genetic and Acquired Risk Factors in Patients with Portal and Mesenteric Venous Thrombosis |
| di Minno G |
- |
Treatment of Glanzmann's Thrombasthenia (GT): A Prospective Observational Registry on the Use of Recombinant Human Activated Factor VII (rFVIIa) and Other Hemostatic Agents |
| Di Minno M |
- |
Recurrent Arterial Thrombosis in Patients Taking Aspirin |
| Di Minno G |
- |
Recurrent Arterial Thrombosis in Patients Taking Aspirin |
| |
- |
Any Relationship Between Inherited Thrombophilia and Bleeding Phenotype or Vascular Disease in Patients with Hemophilia and von Willebrand Disease? |
| Di Minno M |
- |
Assessing Efficacy and Safety of Recombinant Activated Factor VII in Patients with Platelet Functional Abnormalities Undergoing Surgical Procedures |
| Di Minno G |
- |
Assessing Efficacy and Safety of Recombinant Activated Factor VII in Patients with Platelet Functional Abnormalities Undergoing Surgical Procedures |
| Di Minno M |
- |
Troponin I and In-Hospital Outcome in Patients with Non-Massive Central Pulmonary |
| Di Minno G |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| Di Nisio M |
- |
Effects of Clopidogrel on the Rebound Hypercoagulable State in Acute Coronary Syndromes (ACS) Patients after Heparin Discontinuation |
| Di Nisio M |
- |
Interleukin-10, Interleukin-6, and Interferon-g in Advanced Malignancy: Prognostic Relevance and Impact of Low-Molecular-Weight Heparin Administration |
| |
- |
D-Dimer Test in Cancer Patients with Suspected Acute Pulmonary Embolism |
| |
- |
The Prognostic Value of the D-Dimer Test in Cancer Patients Treated with and without Low-Molecular-Weight Heparin |
| Di Paola J |
- |
Oxidant Signaling as a Mediator of Platelet Procoagulant Activity and Coated Platelet Formation |
| Di Paola J |
- |
A Missense Mutation in Exon 28 (C4120T) of the Von Willebrand Factor Gene is the Cause for Von Willebrand Disease in a Large Amish Pedigree |
| Di Renzo L |
- |
DAG Induces Ca2+ Influx through NCKX-TRPC Interaction, Independently of PKC Activity |
| |
- |
Aspirin Does Not Equally Inhibit ThromboxaneA2 Formation in Long-Term Treated Patients |
| Di Santo A |
- |
Effect of Paclitaxel on the Coagulation/Fibrinolytic System Pattern in Cancer and Host's Tumor-Associated Cells |
| |
- |
Inhibition of the Renin-Angiotensin System Modulates the Procoagulant/Fibrinolytic Potential of Human Breast Carcinoma Cells |
| Di Santo S |
- |
Thrombus Growth Is Mediated by Gp91phox |
| Di Sanza C |
- |
Investigation of Molecular Mechanisms Regulating Fibrinogen Secretion |
| Di Stasi F |
- |
Quality of Life in Hemophilic Patients without Inhibitors: The Coche Study |
| |
- |
The Cost of Care of Hemophilic Patients without Inhibitors: The Coche Study |
| Di Stasio E |
- |
Role of Chloride Ions in the Modulation of the Interaction between von Willebrand Factor and Adamts-13 |
| Diakur J |
- |
Biochemical and Pharmacologic Profiling of a Novel Dual Acting Antithrombin Agent with Antiprotease and Antiplatelet Actions |
| Diakur JM |
- |
Novel Dual-Action Anti-Platelet/Anti-Thrombotic Drugs for the Management of HIT |
| Diamandis E |
- |
Analysis of the Differential Expression of uPA, PAI-1, and Tissue Kallikreins hk5, 6, 7, 8, 10, 11, 13 between Primary Ovarian Carcinoma Tissues and Corresponding Omentum Metastases |
| Diamant M |
- |
In Type 2 Diabetes, P-Selectin- But Not CD63 -Exposing Microparticles Are Elevated in the Postprandial State |
| |
- |
The Phospholipid Composition of Cell-derived Microparticles Changes in the Postprandial State |
| Diaz D |
- |
HemosIL ThromboPath: A Chromogenic Assay Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway |
| Diaz M |
- |
Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin |
| DiBenedetto D |
- |
Early Use of Low-Molecular-Weight or Unfractionated Heparin in Patients with Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina. The Global Registry of Acute Coronary Events |
| Diby M |
- |
Coagucheck aPTT versus Central Laboratory aPTT for Anticoagulation Management after Cardiopulmonary Bypass |
| Dickneite G |
- |
Evaluation of Pro-Angiogenic Activity of Factor XIII (FXIII) in Murine Models of Heart Transplantation and FXIII-Deficient Mice |
| Dickneite G |
- |
Thromboelastogram Assays To Detect Hemostatic Abnormalities In Factor XIIIA Deficient Transgenic Mice: Substitution With Human Plasma Factor XIII |
| Dickneitte G |
- |
Impaired Healing of Cutaneous Wounds in Factor XIII-Deficient Mice |
| Didon S |
- |
Characterization of Factor VIII Autoantibodies with Complex Reaction Kinetics is Improved by Heat Inactivation of the Test Plasma to Remove Residual Factor Activity |
| Diehl JL |
- |
Elevated Gas6 Plasma Levels in Patients with Severe Sepsis |
| Diehl S |
- |
Chemically Distinct Anticoagulants Exert Differential Effects on Experimental Melanoma Metastasis |
| Diehm C |
- |
Follow-Up of Patients with Acute Venous Thromboembolism Treated with Ximelagatran for Prophylaxis of Recurrent Events |
| Dielis AWJH |
- |
Changes in Fibrinolysis Activity after Angiotensin II Receptor Blockade in Patients Undergoing Renal Artery Angiography |
| Diener HC |
- |
Prophylaxis of Thromboembolic Complications in Acute Ischemic Stroke with the Low Molecular Weight Heparin Certoparin (PROTECT) |
| Dietcher S |
- |
Enoxaparin (E) and Warfarin (W) Differentially Regulate Tissue Factor (TF), Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activatable Fibrinolytic Inhibitor (TAFI) in Cancer Patients with Thrombosis |
| |
- |
Hyperhomocysteinemia in Cancer Patients with Thrombosis Is Not Associated with Methylene Tetrahydrofolate Reductase (MTHFR) Gene Mutations and Can Be Down Regulated by Low Molecular Weight Heparin Treatment |
| Dietrich U |
- |
Screening of Phage Displayed Random Peptide Libraries Reveals Conformational Epitopes of Inhibitors in a Haemophilia B Patient |
| |
- |
Epitope Mapping During FVIII Inhibitor Eimination With Rituximab Reveals Conformational Epitopes on FVIII and Identifies Small Molecules Blocking Inhibitor and Targeting B Cells |
| Dietrich CP |
- |
Fish Skins as a Source of Heparin-Like GAGs |
| Dietrich U |
- |
Epitope Mapping of Inhibitors in Acquired Haemophilia A |
| Dietz C |
- |
Factor VII Activating Protease (FSAP) Inhibits Angiogenesis in vivo |
| Diez J |
- |
Evaluation of the Anticoagulant Effect of Enoxaparin by Using Clot Based Point of Care Tests |
| Differding JA |
- |
Resuscitation with Lactated Ringers (LR) vs. Normal Saline (NS) Leads to a Hypercoagulable State in an Uncontrolled Hemorrhagic Shock Swine Model |
| Diggs B |
- |
Resuscitation with Lactated Ringers (LR) vs. Normal Saline (NS) Leads to a Hypercoagulable State in an Uncontrolled Hemorrhagic Shock Swine Model |
| diGirolamo N |
- |
Blockade of Microvascular Endothelial Cell Replication, Migration, Tubule Formation, Matrix Angiogenesis and Retinal Neovascularization by siRNA Targeting the Basic Region-Leucine Zipper Transcription Factor cJun |
| Dignat-George F |
- |
Soluble CD146 in Women with Unexplained Pregnancy Loss: A New Insight. A Paired CaseControl Study |
| Dignat-George F |
- |
Endothelial Microparticle Elevation in Uremia: A New Aspect of Endothelial Dysfunction Related to Uremic Toxins |
| Dignat-George F |
- |
Lentiviral Vector-Mediated A20 Gene Transfer to Generate Endothelial (Progenitor) Cells that are Resistant to Inflammatory Stimuli |
| |
- |
Characterization of Human Endothelial Progenitor Cells Under Various Flow Conditions |
| |
- |
Different Patterns of Release of the Soluble Form of the Endothelial Protein C Receptor in Critically Ill Patients |
| Dignat-George F |
- |
Anti-Protein S and Anti-Phosphatidylethanolamine (aPE) Antibodies in Patients with Clinical Features of Antiphospholipid Syndrome (APS) |
| Dignat-George F |
- |
Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST Elevation Acute Coronary Syndromes |
| Dikkeschei B |
- |
Results of the Master Lot Calibration of a New Coagulation Monitoring System for Patient Self Testing |
| |
- |
INR Results of the CoaguChek® PT Test Compare Well with INR Results of International Reference Thromboplastins |
| Diks S |
- |
Signal Transduction by Tissue Factor An Unusual Cytokine Receptor |
| Dillow A |
- |
Modified Whole Blood Clotting Time Assay Detects Recombinant Human FVIIa and rFVIIa Analog NN1731 in Canine Hemophilia a Blood in a Dose-Dependent Fashion |
| Dimichele DM |
- |
A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses |
| DiMichele DM |
- |
Homozygous Protein C Deficiency: Identification of a Mutation with Clinical and Laboratory Heterogeneity |
| Din C-P |
- |
Alteration of Protein Z in Malignant Tumors and Its Significance |
| Din Y |
- |
Alteration of Protein Z in Malignant Tumors and Its Significance |
| Ding K-Y |
- |
The Clinical Significance of Matrix Metalloproteinases Production by Bone Marrow Mononuclear Cells from Patients with Chronic Myeloid Leukemia |
| Ding QL |
- |
Molecular Pathology of Haemophilia B in 19 Unrelated Han's Patients: Identification of Five Novel Mutations |
| |
- |
Genetic Analysis of Chinese Patients with Inherited Afibrinogenemia |
| Ding K |
- |
Clinical Relevance of Expression of VEGF-C and Its Receptors IN Patients with Chronic Myelogenous Leukemia |
| Ding S |
- |
Treatment with Gelatin Absorbed Clodronate in the Management of Immune Thrombocytopenic Purpura in a Rat Model |
| Ding K |
- |
Expression of Tissue Factor Pathway Inhibitor-2 by Retrovirus and Its Effects in Rat Glioma Cells Migration and Invasion |
| |
- |
Clinical Relevance of Expression of VEGF-C and Its Receptors in Patients with Chronic Myelogenous Leukemia |
| Dinisio M |
- |
Effect of Modified Normothrombotic Heparin on Cancer Progression and Metastasis |
| Diniz MJ |
- |
The Spectrum of Mutations and Molecular Pathogenesis of Haemophilia A in 163 Portuguese Patients |
| Diniz EMA |
- |
Homozygous Protein C Deficiency: A Case Report of Neonatal Purpura Fulminans Treated with Activated Protein C Concentrate and High dose of Enoxaparin |
| Dinyari M |
- |
No Difference in Incidences of Thrombosis between Heparin Bonded Catheters and Non Heparin Bonded Catheters in Infants in the Critical Care Unit Following Surgery for Congenital Heart Disease: A Randomised Controlled Triple Blind Study |
| Dippel DWJ |
- |
Pathogenesis of Increased VWF Levels and the Association with the Risk of Ischemic Stroke: Proteolysis, Inflammation or Genetic Variation? |
| Diquattro M |
- |
Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy |
| |
- |
Assessment of Protein S on Hepatopaths at the Last Stage |
| Dirckx C |
- |
Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project |
| |
- |
Comparison of Global Risk of Fatal Cardiovascular Disease in Three European Populations Using SCORE Equations: Results from the IMMIDIET Project |
| Diringer MN |
- |
No Influence of Antiplatelet Therapy on the Outcome of Acute Intracerebral Haemorrhage Treated with Recombinant Activated Factor VII |
| Diringer MN |
- |
Effects of Recombinant Activated Factor VII on Perilesional Oedema in Patients with Acute Intracerebral Haemorrhage |
| Dirks C |
- |
Walking and Modulation of Cardiovascular Risk Factors in Three European Populations: Results from the IMMIDIET Project |
| Dissanayake MP |
- |
Identification of the Region of FXIIIA Responsible for Binding to the Alpha Chain of Fibrin(ogen) |
| Distante A |
- |
Homocysteine (Hcy) Stimulates Endothelial Vascular Cell Adhesion Molecule(VCAM)-1 Via Nuclear Factor(NF)-kB Activation Induced by an Increase of Reactive Oxygen Species (ROS): Protective Role by Natural Antioxidants |
| |
- |
Anti-Angiogenic Action of Peroxisome Proliferator-Activated Receptor(PPAR)g Ligands Through Cox-2-Mediated MMP-9 Expression and Release |
| |
- |
Anti-Inflammatory and Anti-Angiogenic Effects of the Omega-3 Fatty Acid Docosahexaenoate (DHA, 22:6 n-3) Through ERK1/2-Mediated Inhibition of Cyclooxygenase (COX)-2 Expression |
| Divoka M |
- |
Clinical Phenotype of Hemophilia and Prothrombotic Gene Mutation |
| Djemal S |
- |
Management of Anticoagulated Patients Undergoing Dental Treatment |
| Djordjevic V |
- |
Pediatric Thrombosis |
| Djordjevic V |
- |
Combined Genetic Risk Factors in Thrombophilic Serbian Population |
| Djuric DM |
- |
Platelets/Endothelium Interaction and Oxidative Stress in Isolated Guinea-Pig Heart: Focus on L-Arginine/ No System and Superoxide Anion Radical Production |
| Dlott J |
- |
Improved Oral Anticoagulant Therapy Monitoring by Eliminating ISI and MNPT from INR Determinations |
| Dmitrieva A |
- |
Hyperhomocysteinemia Is a Significant Risk Factor for Recurrent Early Pregnancy Loss in Russia |
| Dobaczewski G |
- |
Immunate S/D Results of a Phase III, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of Immunate Solvent Detergent in Previously Treated Patients with Severe or Moderately Severe Hemophilia A |
| Dobrovolsky A |
- |
Matrix Metalloproteinases and Markers of Thrombin Generation in Patients with Restenosis after Percutaneous Coronary Interventions |
| Dobrovolsky A |
- |
Homocystein and Hemostatic Variables in Young Postinfarction Patients |
| |
- |
Relation of Changes in D-dimer and Factor VIIa Levels after Treatment with Heparins to Clinical Outcomes of Unstable Angina |
| Dockal M |
- |
Quantification of ADAMTS13 Antigen Levels in Healthy Donors and Patients with Thrombotic Microangiopathies by a Newly Developed Sandwich ELISA |
| Dodds A |
- |
Diagnostic Dilemma of a Patient with Strong Lupus Anticoagulant and Intramuscular Haemorrhage, Requiring Treatment with Recombinant FVIIa |
| Dodt J |
- |
A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates |
| Doering CB |
- |
High-Level Expression of Porcine Factor VIII from Genetically-Modified Bone Marrow-Derived Cell Types |
| Doerr H |
- |
Direct INR Determination by Use of Linear or Orthogonal Regression |
| Doggen CJM |
- |
MTHFR C677T and the Risk Of Venous Thrombosis Interaction with Factor V Leiden and Prothrombin G20210A Mutations |
| |
- |
Body Weight and Height, Obesity and Factor V Leiden. Risk of Venous Thrombosis in the Mega Study |
| |
- |
Effect of Regular Sports Activities on the Risk of Venous Thrombosis: Results from the MEGA Study |
| |
- |
Association of Coagulation Factor VIII Haplotypes with Factor VIII Activity and the Risk of Venous and Arterial Thrombosis |
| |
- |
The Association of Prothrombin A19911G Polymorphism with Plasma Prothrombin Activity and Venous Thrombosis in a Large Population-Based Case-Control Study; Results of the MEGA Study |
| |
- |
Increased Risk of Venous Thrombosis after Orthopedic and General Surgery. Results of the MEGA Study |
| |
- |
Upper Extremity Venous Thrombosis; Risk estimations for Surgery, Plaster Cast, Unusual Activities and Exercise |
| |
- |
Factor VIII Coagulant Activity and Antigen Levels Increase the Risk of Venous Thrombosis; Results of the MEGA Study |
| Doh H |
- |
A Novel Fibrinogen Variant (Fibrinogen Seoul II: AaGln328Pro) with Impaired Fibrin Aa-chain Cross-linking |
| Dohiguchi Y |
- |
Safety for Stroke in Appling Modified Recombinant T-PA, Monteplase, in Patients with Acute Myocardial Infarction in Japanese Real Clinical World |
| |
- |
Safety and Potential Factors Associated with Use of Monteplase (Modified t-PA) in Routine Clinical Practice |
| Doi P |
- |
Endothelial Protein C Receptor Is Expressed by CD83+ Dendritic Cells in the Human Gut Mucosa and Is Down-Regulated by Bacterial Antigens on Monocyte-Derived Dendritic Cells |
| Dokou E |
- |
Factor V Leiden and R2 Mutations, Prothrombin G20210A Mutation and Osteonecrosis |
| |
- |
Assessing Acquired and Inherited Factors in Cases of Idiopathic and Secondary Pulmonary Embolism |
| Dolan G |
- |
Evaluation of dHPLC in the Genetic Analysis of Fibrinogen Disorders |
| |
- |
Raised Blood Leukocyte Counts Markedly Alter Platelet Aggregation Extent induced by ADP and ATP via CD39 |
| Dolce A |
- |
Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial |
| Domagala T |
- |
Rapid Antithrombotic and Anti-platelet Effects of Simvastatin and Micronized Fenofibrate in Patients with Hypercholesterolemia |
| Domagala TB |
- |
Thrombin Generation after Therapy with Lipid-Lowering Drugs in High Cardiovascular Risk Subjects Supplemented with Folic Acid |
| |
- |
Venous Thromboembolism, Arterial Thrombosis and Plasma Homocysteine Levels in Families with Inherited Thrombophilia |
| Domenech P |
- |
Study of the Prethrombotic State in Patients at High Risk of Developing Type 2 Diabetes Mellitus |
| |
- |
Effect of Cigarrette Smoking on Fibrinogen and Von Willebrand Factor and Their Association with Risk Factors for Microangiopathy |
| Donadini M |
- |
D-Dimer and the Risk of Venous Thromboembolism in Medical Patients |
| Donat[etilde] F |
- |
Defining the Interaction between Cleaved High Molecular Weight Kininogen (HKa) and Tropomyosin |
| Donatelli F |
- |
Impaired Bradykinin Response to Ischemia and Exercise in Patients with Mild Congestive Heart Failure During Angiotensin-Converting Enzyme Treatment. Relationships with Endothelial Function, Coagulation and Inflammation |
| Donati MB |
- |
C-Reactive Protein and Its Determinants in European Populations at Different Risk of Cardiovascular Disease: Results from the IMMIDIET Project |
| |
- |
Leukocyte Activation in Myeloproliferative Disease |
| Donati MB |
- |
Inhibition of the Renin-Angiotensin System Modulates the Procoagulant/Fibrinolytic Potential of Human Breast Carcinoma Cells |
| Donati MB |
- |
The -675 4G/5G Plasminogen Activator Inhibitor-1 Promoter Polymorphism in House Dust Mite Sensitive Allergic Asthma Patients |
| Donati M |
- |
Effect of Paclitaxel on the Coagulation/Fibrinolytic System Pattern in Cancer and Host's Tumor-Associated Cells |
| Donati MB |
- |
Walking and Modulation of Cardiovascular Risk Factors in Three European Populations: Results from the IMMIDIET Project |
| |
- |
Parnaparin Prevents Platelet-PMN Leukocyte Interaction: New Clues to the Antithrombotic Properties of Low Molecular Weight Heparin |
| |
- |
Parnaparin Prevents the Upregulation of Platelet-Leukocyte Interaction in Whole Blood |
| |
- |
Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project |
| |
- |
Polymorphonuclear Leukocytes Express Tissue Factor after Activation with P-Selectin |
| |
- |
Association Between -675 4G/5G Polymorphism of the PAI-1 Gene and Obesity in Men: Longitudinal Findings of the Olivetti Heart Study |
| |
- |
Comparison of Global Risk of Fatal Cardiovascular Disease in Three European Populations Using SCORE Equations: Results from the IMMIDIET Project |
| |
- |
Polyphenolic Components of Extra Virgin Olive Oil: Effect on Arterial Thrombosis and Bioavailability in Rats |
| Dong N |
- |
Hereditary Plasminogen Activator Inhibitor-1 Deficiency Related to Ala15Thr Mutation in Its Signal Peptide |
| |
- |
Identification of Two Novel Mutations in ADAMTS13 Gene in A Pregnant Patient with Congenital Thrombotic Thrombocytopenic Purpura |
| |
- |
Construction of a Phage Display Library of Human Fab Antibodies against Human Platelet Membrane Glycoprotein IIb/IIIa |
| Dong JF |
- |
Effects of Hypothermia and Acidosis on Swine Platelet Activation and Aggregation in vivo |
| Dong N |
- |
A Novel Deletion Mutation of Von Willebrand Factor Associated with Type 3 Von Willebrand Disease |
| |
- |
A Monoclonal Antibody Against Platelet GPVI Impaires the Interaction Between Platelet and Collagen |
| Dong JF |
- |
Cleavage of Ultra-large von Willebrand Factor by ADAMTS-13 Under Flow Conditions |
| Donna E |
- |
Interstitial Pulmonary Lesions in Patients with Recurring Severe ITP |
| Donnelly JC |
- |
The Impact of Acquired Thrombophilia on Maternal and Fetal Wellbeing in a Low-risk Population |
| Dooley M |
- |
Unusual Haplotypic Associations with Marked GPIIIa Allelic Expression Bias in the Platelets of PlA2 Heterozygotes |
| Doornebal CW |
- |
von Willebrand Factor in Platelets |
| Dörje C |
- |
A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients |
| Dorling A |
- |
Bone Marrow-Derived CD34+ Cells, Modified to Express Anticoagulants on Differentiation, Promote Repair to a Pre-Injured State after Endovascular Injury |
| |
- |
Thrombin Is Required for Inflammatory Cell Recruitment and Graft Infiltration During Acute Humoral Xenograft Rejection |
| Dorn J |
- |
Analysis of the Differential Expression of uPA, PAI-1, and Tissue Kallikreins hk5, 6, 7, 8, 10, 11, 13 between Primary Ovarian Carcinoma Tissues and Corresponding Omentum Metastases |
| Dörner T |
- |
Arg485Pro Mutation in the Gamma-Glutamyl Carboxylase Contributes to Three Unrelated German VKCFD Type 1 Patients with Compound Heterozygous Mutations |
| Dorsam RT |
- |
ErkMediated Thromboxane A2 Production Is Essential for von Willebrand Factor/GPIbInduced Fibrinogen Receptor Activation in Human Platelets |
| |
- |
Molecular Mechanism and Functional Implications of Thrombin-Mediated Tyrosine Phosphorylation of PKCd in Platelets |
| |
- |
Hematopoeitic Lineage Cell-Specific Protein-1 (HS1) Is a Functionally Important Signaling Molecule Downstream of GPVI Stimulation in Platelets |
| Doti C |
- |
Fibrinolytic Peritoneal Response to Laparoscopic Surgery |
| |
- |
Validation of a Clinical Score (CS) Plus D-Dimer (DDi) Combination As a Diagnostic Strategy to Exclude Pulmonary Embolism (PE) |
| |
- |
Failure of the Outpatient Bleeding Risk Index to Predict Major Bleeding in Older Patients Receiving Coumarin for Atrial Fibrillation |
| |
- |
Neonatal DIC by Enterovirus. Favorable Outcome with Maternal Plasma Transfusion |
| Dotsenko O |
- |
Heterogeneity of Integrin Expression on Platelet Microparticles. Use of A Snake Venom Disintegrin as a Functional Probe |
| Dotsenko O |
- |
Platelet-Derived Microparticles Bind Heparin with High Affinity |
| |
- |
Hypertonic Stress Alters the Yield and Type of Microparticles Produced by Haemopoietic Cells |
| Dou L |
- |
Endothelial Microparticle Elevation in Uremia: A New Aspect of Endothelial Dysfunction Related to Uremic Toxins |
| Douard P |
- |
Perinatal or Fetal Thrombosis in Babies Allowing Detection of the Anti-phospholipid Syndrome in Mothers |
| Douglas CWI |
- |
A Comparison of the Effects of Shear Stress on the Interactions between Streptococcus sanguis and Staphylococcus aureus with Perfused Human Blood Platelets |
| Dougou-Tzaou S |
- |
An Inquiry into Death Causes Based on Autopsy Findings |
| Douketis J |
- |
Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial |
| |
- |
Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH) |
| Douketis JD |
- |
Brain Natriuretic Peptide in Hemodynamically Stable Acute Pulmonary Embolism |
| Douketis J |
- |
Low-Molecular-Weight Heparin or Unfractionated Heparin as Bridging Therapy in Patients on Long-term Oral Anticoagulants: Results from the REGIMEN Registry |
| |
- |
Bridging Anticoagulation With Enoxaparin Is Effective and Safe in Patients with a Mechanical Heart Valve (MHV) Who Require Temporary Interruption of Vitamin K Antagonist (VKA) Therapy |
| Dova L |
- |
Factor V Leiden and R2 Mutations, Prothrombin G20210A Mutation and Osteonecrosis |
| |
- |
Assessing Acquired and Inherited Factors in Cases of Idiopathic and Secondary Pulmonary Embolism |
| |
- |
Is Screening for Thrombophilia Mutations Necessary Prior to Free Functional Muscle Transfer? |
| Dovifat C |
- |
A Multicenter Controlled Trial of Anticoagulation Patient Self-Management in Germany Using the Protime System |
| Dowling N |
- |
Multi-Site Comparison of Platelet Function Testing |
| Dowling NF |
- |
Sickle-cell Trait and the Risk of Venous Thromboembolism |
| Dowling N |
- |
Treatment and Management of Women with Bleeding Disorders and Menorrhagia (WBDM) Study: Laboratory Diagnosis |
| Dowling NF |
- |
Associations of Factor VIII (FVIII) and von Willebrand Factor Antigen (VWF:Ag) with Race, Age, ABO Blood Group and Co-Morbid Conditions |
| |
- |
Quality of Life (QoL) Evaluation in Women with Menorrhagia and Inherited Bleeding Disorders |
| Dowling GJ |
- |
Brachial Artery Thrombosis in Infants: A Multidisciplinary Algorithm for Limb Salvage |
| Dowling D |
- |
The Association Between Diabetes and Venous Thromboembolism in African Americans and Caucasians and the Relationship with Peroxisome Proliferator-Activated Receptor Polymophisms |
| Dowling N |
- |
The Relationship Between Genetic Variants in the Endothelial Protein C Receptor and Venous Thromboembolism |
| Downey C |
- |
The Mechanism of Alpha-1-Protease Inhibitor Inactivation During Sepsis-Induced Disseminated Intravascular Coagulation |
| |
- |
Activated Protein C (APC) Bound to Microparticle-Associated Endothelial Protein C Receptor (EPCR) Occurs in vivo and Has Anticoagulant Properties |
| |
- |
Inactivation of Factor V during Sepsis-Induced Disseminated Intravascular Coagulation: Reconciliation of Total Factor V Activity with Its Cleavage and Inactivation as Assessed by SDS-PAGE and Immunoblotting |
| |
- |
In Patients with the Biphasic Waveform, Lipoprotein Complexation Does Not Retard C-Reactive Protein Induced Complement Activation |
| Dr Torres O |
- |
Use of Recombinant VIIa Factor in the Treatment of Bled in Central Nervous System of Haemophilic Patients with Inhibitor against Factor VIII |
| Dr. Pollola J |
- |
Use of Recombinant VIIa Factor in the Treatment of Bled in Central Nervous System of Haemophilic Patients with Inhibitor against Factor VIII |
| Dra Cermelj M |
- |
Use of Recombinant VIIa Factor in the Treatment of Bled in Central Nervous System of Haemophilic Patients with Inhibitor against Factor VIII |
| |
- |
Use of Recombinant VIIa Factor in the Treatment of Bleed in Central Nervous System of Haemophilic Patients with Inhibitor Against Factor VIII |
| Dra Ferro AM |
- |
Use of Recombinant VIIa Factor in the Treatment of Bled in Central Nervous System of Haemophilic Patients with Inhibitor against Factor VIII |
| Dra Ferro Ana M-C |
- |
Use of Recombinant VIIa Factor in the Treatment of Bleed in Central Nervous System of Haemophilic Patients with Inhibitor Against Factor VIII |
| Dra Ouviña S |
- |
Use of Recombinant VIIa Factor in the Treatment of Bled in Central Nervous System of Haemophilic Patients with Inhibitor against Factor VIII |
| Dra Ouviña S |
- |
Use of Recombinant VIIa Factor in the Treatment of Bleed in Central Nervous System of Haemophilic Patients with Inhibitor Against Factor VIII |
| Dra Paz A |
- |
Use of Recombinant VIIa Factor in the Treatment of Bled in Central Nervous System of Haemophilic Patients with Inhibitor against Factor VIII |
| Dragomir E |
- |
VCAM-1 as Target for Immunoliposome-Mediated Drug Delivery to Activated Endothelial Cells |
| Drechsler WI |
- |
Gait Alterations Exist in Children with Haemophilia after Relatively Few Haemarthroses and Despite Prophylaxis A 3D Motion Analysis Study |
| Drenth AF |
- |
Consideration of HIT Antibody Isotype in Interpretation of the Serotonin Release Assay |
| |
- |
Arresting Platelet Activation Induced by HIT Antibodies Using a Desulfated Heparin |
| Dressler M |
- |
Thrombophilia in Inherited Antithrombin Deficiency |
| Dressman H |
- |
Gene Expression Profiling in Antiphospholipid Syndrome Reveals Distinct Molecular Signatures with Diagnostic Value |
| Drevens[breve]ek G |
- |
New Direct Thrombin Inhibitors Build on Azaphenylalanine Scaffold Antithrombotic Effect in Two Rat Venous Thrombosis Models |
| Drexler A |
- |
Successful Use of Bivalirudin in the Treatment of Patients Suspected, or at Risk of, Heparin-Induced Thrombocytopenia |
| |
- |
Heparin-Platelet Factor 4 Antibodies are Common among Recently Hospitalized Patients with Acute Coronary Syndromes Presenting to the Emergency Department |
| |
- |
Heparin Platelet Factor 4 Antibody Formation in Patients Receiving Bivalirudin or Heparin for Off-Pump Coronary Artery Bypass Surgery |
| Dreyfus M |
- |
Molecular Basis of MYH9-Related Disorders in a Series of Ten Families |
| Drigo P |
- |
Cerebral Sinovenous Thrombosis in Children |
| Drijfhout JW |
- |
Alternatively Spliced Soluble Tissue Factor in Mice |
| Drogemuller CJ |
- |
Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis |
| Dropinski J |
- |
Anti-thrombotic Action of Clopidogrel is More Pronounced in Patients with Coronary Artery Disease Carrying PlA2 Allele of Beta3 Integrin |
| |
- |
Complementary Antithrombotic Effects of Aspirin and Clopidogrel Based on PlA1/A2 Glycoprotein IIIa Polymorphism |
| Dropinski J |
- |
Rapid Antithrombotic and Anti-platelet Effects of Simvastatin and Micronized Fenofibrate in Patients with Hypercholesterolemia |
| |
- |
Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism |
| Dropi[nacute]ski J |
- |
Thrombin Generation after Therapy with Lipid-Lowering Drugs in High Cardiovascular Risk Subjects Supplemented with Folic Acid |
| Drouet L |
- |
Usefulness of Platelet VASP Quantification to Monitor Antiplatelet Treatment by Thienopyridines |
| |
- |
Prolonged Extracorporeal Life Support (ECLS) in Patients with Severe Membrane Stabilizing Agent (MSA) Poisonings: Hemostatic Management Requires only Minimal Doses of Heparin |
| |
- |
We Still Need to Organize French Anticoagulation Clinics |
| Drouet L |
- |
The Predictive Value of D-Dimers on the Occurrence of Thromboembolic Events and Death: A Prospective Multicentric Study |
| |
- |
Interaction between Paracetamol and Warfarin: A Double-Blind Placebo-Controlled Randomised Study |
| Drouet L |
- |
A Multi-Rule Expert System to Manage OAT in Most Real-Life Clinical Situations |
| Drown P |
- |
The Crystal Structure of Unliganded Thrombin Identifies Regions Involved in Allosteric Regulation by Thrombomodulin |
| D'Rozario J |
- |
Case Series of Acquired Factor VIII Inhibitors: Profile in the Australian Capital Territory and Review of Literature |
| Drugan C |
- |
Associated Vitamin K Deficiency in Gaucher Disease Patients |
| Drummond GR |
- |
Nitric Oxide Suppresses NADPH Oxidase-Dependent Superoxide Production in Human Endothelial Cells and Arteries |
| Drummond O |
- |
Plasma Prion Protein (PrPC) in Patients with Vascular Diseases |
| Druzhinin AV |
- |
Influence of Factor XI Activation by Thrombin on Coagulation Kinetics: A Mathematical Model |
| Druzhinin AV |
- |
The Effects of Platelets on Activation Threshold of the Coagulation System |
| Druzhinin AV |
- |
Platelet Activation by Limited Proteolysis of PAR-1, and -4 and its Role in Activation of Coagulation: a Mathematical Model |
| D'Souza R |
- |
Effect of TGN 255, a Novel Intravenous Direct Thrombin Inhibitor, on the Prolongation of ACT in Patients Undergoing Haemodialysis |
| Du X |
- |
A Critical Role for 14-3-3 Protein in Regulating the VWF Binding Function of the Platelet Glycoprotein Ib-IX |
| Du JW |
- |
The Expression of Recombinant Adeno-Associated Virus/Human Coagulant Factor IX Gene in Human/Rat Gut Epithelial Cells |
| Du X |
- |
Recent Insights in Adhesion-Dependent Signalling: From the Glycoprotein Ib-IX to the Integrin aIIbb3 |
| Du J |
- |
Study on Platelet-Associated Tissue Factor and Its Significance in Thrombotic Diseases |
| Dubart-Kupperschmitt A |
- |
Lentivirus Destruction and DC-SIGN Expression by Platelets and Megakaryocytes |
| Dubois C |
- |
Role of the Bile Salt Dependent Lipase (BSDL) in Thrombus Formation: in vitro and in vivo Study |
| Dubois C |
- |
Molecular Pathways Involved in Thrombus Formation in vivo after FeCl3 or Laser-Induced Injury |
| |
- |
Calcium Mobilization Required for Firm Platelet Attachment is Dependent upon Both ADP and Thromboxane A2 during Thrombus Formation in a Living Mouse |
| Duboscq C |
- |
Failure of the Outpatient Bleeding Risk Index to Predict Major Bleeding in Older Patients Receiving Coumarin for Atrial Fibrillation |
| |
- |
Validation of a Clinical Score (CS) Plus D-Dimer (DDi) Combination As a Diagnostic Strategy to Exclude Pulmonary Embolism (PE) |
| Duboscq C |
- |
Fibrinolytic Peritoneal Response to Laparoscopic Surgery |
| Duboscq C |
- |
Neonatal DIC by Enterovirus. Favorable Outcome with Maternal Plasma Transfusion |
| Duca ML |
- |
Evaluation of the New ACL TOP Coagulation Analyser from IL |
| Ducasse C |
- |
Mutations in the Protein C Binding Site of Factor VIII Lead to the Resistance of Activated Protein C Cleavage |
| |
- |
Selected Human/Porcine Point Substitutions Generated A Human FVIIIa with an Improved Stability |
| Duclos M |
- |
Protein Z Polymorphisms, Protein Z Plasma Concentration and Severe Pre Eclampsia |
| |
- |
Protein Z Polymorphisms and Cerebral Venous Thrombosis |
| Ducruet T |
- |
The VEINES-QOL/Sym Questionnaire Is a Valid and Reliable Measure of Quality of Life in Patients with Deep Venous Thrombosis |
| Dudani A |
- |
Interaction of Plasminogen and Angiostatin with Heat Shock Proteins |
| Dudbridge F |
- |
Functional Differences in the Response of Platelets to Collagen That Are Linked to Glycoprotein VI Genotype Are Also Associated with Differences in Platelet Gene Expression Profiles |
| Dudenhausen J |
- |
Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial |
| Dudkiewicz P |
- |
Interstitial Pulmonary Lesions in Patients with Recurring Severe ITP |
| Dudlova J |
- |
Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) |
| Duff R |
- |
Interaction of BAY 59-7939 A Novel, Oral, Direct Factor Xa Inhibitor with Antiplatelet Agents: Monitoring and Therapeutic Applications |
| |
- |
Argatroban Interactions with Low Molecular Weight Heparins: Pharmacologic Implications |
| Dufresne J |
- |
The Whole Blood Platelets Aggregation Test for HIT Diagnosis |
| Duga S |
- |
Type II Mutation (Glu117stop) Causes Factor XI Deficiency by Inducing Allele Specific mRNA Degradation |
| Duga S |
- |
Eight Novel Mutations in FXI Gene |
| Duga S |
- |
In-vitro Expression and Functional Characterization of Four Mutations Causing Factor XI Deficiency |
| Duggan C |
- |
Management of Anticoagulated Patients Undergoing Dental Treatment |
| |
- |
Satisfaction and Safety of Two Domiciliary Anticoagulation Services for Mobility-impaired Patients: Preliminary Trial Findings |
| Dujols C |
- |
Low Molecular Weight Fucoidan Is More Effective Than Low Molecular Weight Heparin in Preventing Arterial Thrombosis in a Rabbit Model |
| Dulí[ccaron]ek P |
- |
The Comparison of Thrombophilic Potential of F V Leiden and F II20210A in Heterozygous Form in Individuals from the East Bohemian Region |
| Dulicek P |
- |
Lupus Anticoagulant and FV Leiden Associated with Clozapine Use and Venous Thromboembolism |
| Duli[ccaron]ek P |
- |
Acetylsalicylic Acid (ASA) Resistance in Patients with Ischemic Heart Disease (IHD) as Bioindicator of the Treatment Strategy |
| Dumont B |
- |
Glycoprotein VI Structure-Function Relationship: Identification of Collagen Binding Domains Using GPVI/FcaR Chimera |
| Duncan E |
- |
Accuracy of a Whole Blood D-Dimer Assay (SimplifyTM) for Deep Vein Thrombosis, When Performed Using Venous Whole Blood and Frozen Plasma in a Cohort Patients with Suspected Deep Vein Thrombosis |
| Duncan A |
- |
Flow Cytometric Analysis of Platelet Activation Via Recombinant Factor VIIa |
| |
- |
Factor V Inhibitor Acquired after Exposure to High-Purity Topical Bovine Thrombin during Orthopedic Surgery |
| |
- |
Reproducibility and Utility of a Flow Cytometric-Based Annexin V Competition Assay for Evaluation of the Antiphospholipid Syndrome |
| Duncan EM |
- |
FXI Deficiency in South Australia: Diversity of Causative Mutations within a Small Group of Affected Individuals |
| Duncan EM |
- |
A High Prevalence of Ankle Arthropathy in Mild and Moderate Haemophilia A in South Australia and a Threshold Effect of FVIII Level on Its Occurrence |
| |
- |
Kinetics of Factor VIII Assays in Mild Haemophilia A: Implications for Choice of Diagnostic Assay |
| Duncan MK |
- |
Heparin-Platelet Factor 4 Antibodies are Common among Recently Hospitalized Patients with Acute Coronary Syndromes Presenting to the Emergency Department |
| Duncan E |
- |
The Accuracy of the Wells Pretest Probability Assessment Model for Proximal Deep Vein Thrombosis When Applied by Emergency Department Doctors in South Australia |
| Dundar S |
- |
Retrospective Open Multicenter Study on the Efficacy and Safety of Activated Prothrombin Complex (Feiba®) in Haemorrhage and Surgical Interventions in Haemophilia Patients with Inhibitor and in Patients with Rare Bleeding Disorders in Turkey |
| Dunkley S |
- |
Successful Treatment of a High Titre Factor VIII Inhibitor with Rituximab Alone |
| |
- |
A Familial Platelet Function Disorder Associated with Abnormal Signaling Through the Glycoprotein VI Pathway |
| Dunn A |
- |
Leukemia after P32 Radionuclide Synovectomy for Hemophilic Arthropathy |
| Dunn EJ |
- |
Molecular Mechanisms Involved in the Resistance of Fibrin to Clot Lysis in Subjects with Type 2 Diabetes Mellitus |
| Dunn AS |
- |
Low-Molecular-Weight Heparin or Unfractionated Heparin as Bridging Therapy in Patients on Long-term Oral Anticoagulants: Results from the REGIMEN Registry |
| Dunoyer-Geindre S |
- |
Atherosclerosis in LDLR Knock-Out Mice Immunized with b2GP1: Effect of High Cholesterol Diet and Pravastatin Supplementation |
| Dunoyer-Geindre S |
- |
The Activation of Mouse Fibroblasts by Antiphospholipid Antibodies Requires TLR2 |
| |
- |
Isolation, Characterization and Angiogenic Potential of Human Mesenchymal Stem Cell-Derived Endothelial-Like Progenitor Cells |
| Dunsch D |
- |
Epitope Mapping During FVIII Inhibitor Eimination With Rituximab Reveals Conformational Epitopes on FVIII and Identifies Small Molecules Blocking Inhibitor and Targeting B Cells |
| Dunska V |
- |
Twins Pregnancy in the Case of Essential Thombocythemia: A Case Report |
| Dupe R |
- |
Anti-coagulant Activity of TGN 255, a Novel Synthetic Direct Thrombin Inhibitor |
| |
- |
The Utility of TGN 255 in a Model of Coronary Pulmonary Bypass and Simulated Mitral Valve Repair in the Dog |
| Dupouy D |
- |
Microparticles from Smooth Muscle Cells Induce Endothelial Dysfunction, a Phenomenon Prevented by Glycoprotein IIb/IIIa Antagonists |
| Durackova Z |
- |
Does Pycnogenol Intensify Efficacy of Acetylsalicylic Acid in the Inhibition of Platelet Function? |
| Durand E |
- |
Low Molecular Weight Fucoidan Is More Effective Than Low Molecular Weight Heparin in Preventing Arterial Thrombosis in a Rabbit Model |
| Duranovic V |
- |
Ischemic Childhood Stroke and Lipoprotein (a) |
| Durante-Mangoni E |
- |
Oxidative Modification of Low-density Lipoprotein (LDL) and OxLDL/b2GPI Complexes in Patients with Infectious Endocarditis: Possible Role in Aortic Valve Disease |
| Dureau G |
- |
MIP-1b and VE-Cadherin Are Implicated in Acute Rejection in Human Heart Transplantation |
| Dureuil B |
- |
Heparin-PF4 Elisa Antibodies Detection Is Not Relevant to Diagnose HIT During Sepsis |
| Durham T |
- |
Phase 1 Pharmacokinetic, Pharmacodynamic, and Safety Evaluation of a Novel Rapidly Reversible Intravenous Platelet P2Y12 ADP Receptor Antagonist, INS50589 |
| Durin-Assolant A |
- |
Immune Tolerance Induction with Highly Purified Plasma-Derived Factor VIII Containing Von Willebrand Factor in Hemophilia a Patients with High-Responding Inhibitors |
| Düring C |
- |
Long-Term Safety and Efficacy Data on Neonatal Thromboembolism Treated with Dalteparin or Enoxaparin: A Comparison of Once Daily Versus Twice Daily Administration |
| D'Ursi P |
- |
Electrostatic Properties of Naturally Occurring Protein C Mutants by Computational Analysis |
| Dusanter-Fourt I |
- |
HZF as a Candidate Gene for Gray Platelet Syndrome (GPS) |
| Dusek L |
- |
Treatment of Life Threatening Bleeding with rFVIIa in 20012004 in Czech Republic. Presentation of 126 Cases with the Help of UniSeven Registry |
| |
- |
Bleeding Prophylaxis in Children with Haemophilia A/B Using Plasma-derived Concentrates Immunate/Immunine Prospective Survey |
| Du[scaron]ek L |
- |
Project HemIS (Haemophilia Information System): Multicentric Information System of Patients with Haemophilia |
| Dusse LMS |
- |
Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers |
| |
- |
Monocytes and Plasma Tissue Factor Levels in Normal Individuals and Patients with Lower-Limbs Deep Venous Thrombosis: Potential Diagnostic Tools? |
| |
- |
Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes |
| |
- |
Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment |
| |
- |
Factor V Leiden: An Important Risk Factor for Venous and Arterial Thrombosis in Brazilian Patients |
| |
- |
Natural Anticoagulation Evaluation in Type 2 Diabetes |
| Dusting GJ |
- |
Nitric Oxide Suppresses NADPH Oxidase-Dependent Superoxide Production in Human Endothelial Cells and Arteries |
| |
- |
Nitric Oxide Modulates NADPH Oxidase Function through Haemoxygenase-1 Induction in Human Endothelial Cells |
| Dutra A |
- |
Sticky Platelet Syndrome Is a Cause of Cerebral Venous Thrombosis |
| Dutrillaux F |
- |
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects |
| |
- |
Management of Glanzmann's Thrombasthenia Surgery: Contribution of Thrombelastogram (ROTEM®) |
| Dutt T |
- |
The Application of New Diagnostic Guidelines in Type 1 von Willebrand Disease to Patients Previously Diagnosed Under the UK 1995 Guidelines. A Single Centre Paediatric Experience |
| Dvorak AM |
- |
Angiogenesis Update 2005: How Tumors Make Bad Blood Vessels |
| Dvorak HF |
- |
Angiogenesis Update 2005: How Tumors Make Bad Blood Vessels |
| Dworakowska D |
- |
Concentration of TAFI and D-Dimers in Radically Operated Non-Small Cell Lung Cancer Patients |
| |
- |
Correlation Between Selected cloTting Factors Parameters and Apoptosis of Peripheral T Lymphocytes in Non-Small Cell Lung Cancer |
| |
- |
Expression of the Death Receptor Fas (CD95) on Peripheral T Lymphocytes in Correlation with Selected Clotting System Parameters in Non-Small Cell Lung Cancer |
| |
- |
Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients |
| |
- |
Concentration of TF and TFPI in Non-Small Cell Lung Cancer |
| |
- |
AT, TAT and F1+F2 in Radically Operated Non-small Cell Lung Cancer Patients |
| Dworakowski R |
- |
AT, TAT and F1+F2 in Radically Operated Non-small Cell Lung Cancer Patients |
| |
- |
Concentration of TF and TFPI in Non-Small Cell Lung Cancer |
| |
- |
Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients |
| |
- |
Expression of the Death Receptor Fas (CD95) on Peripheral T Lymphocytes in Correlation with Selected Clotting System Parameters in Non-Small Cell Lung Cancer |
| |
- |
Correlation Between Selected cloTting Factors Parameters and Apoptosis of Peripheral T Lymphocytes in Non-Small Cell Lung Cancer |
| |
- |
Concentration of TAFI and D-Dimers in Radically Operated Non-Small Cell Lung Cancer Patients |
| Dwyre L |
- |
Validation of Overt Disseminated Intravascular Coagulation (DIC) Scoring Algorithm Use in Critically Ill Patients: Correlation with Inflammatory Markers and APACHE and SOFA Scores |
| Dyck J |
- |
Incorporation of a Comprehensive Pediatric Thrombosis Program as Part of the Multidisciplinary Care Team for Children with Congenital Heart Disease: A Prospective Cohort Study |
| Dyr JE |
- |
A Multicentre Study on 50 Cases with Thrombotic Thrombocytopenic Purpura in the Czech Republic: Recurrent Mutation in ADAMTS13 Gene as a Cause of a Hereditary Thrombotic Thrombocytopenic Purpura |
| Dyson JM |
- |
The Platelet Actin Cytoskeleton Dynamically Reorganizes into Podosomes Upon Cell Adhesion. Identification of a Novel Actin-rich Adhesive Structure in Human Platelets |
| Dyszkiewicz-Korpanty A |
- |
Complementary Antithrombotic Effects of Aspirin and Clopidogrel Based on PlA1/A2 Glycoprotein IIIa Polymorphism |
| Dytrychová V |
- |
Our Experiences with the Determination of ProC Global Test and with the Interpretation of Results |
| Dziedzina S |
- |
Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism |
| Dzoljic M |
- |
Lung-Protective Mechanical Ventilation Attenuates Fibrin Generation in Healthy Lungs |